Join or Renew Your Membership Join

Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | P1 - Poster Session 1

Sunday 04/23/23
08:00 AM - 09:00 AM EST Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Sleep, Aging, Dementia, Cognitive, and Behavioral Neurology, Autoimmune Neurology, Education, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-ophthalmology/Neuro-otology, Neuro Trauma and Critical Care
0.00 CME credit

Program Materials Program Evaluations

Event Timeline
08:00 AM - 09:00 AM EST Abstract 1-001 - Assessing Neuropsychology Testing Variation at Level IV Epilepsy Centers
Patrick Landazuri, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 1-002 - Short versus Long video-EEG in Diagnosis of Psychogenic Non-Epileptic Spells (PNES): Yield and Cost-Effectiveness
Haneen Faisal Al Refa'i
08:00 AM - 09:00 AM EST Abstract 1-004 - Feasibility and Insights from Automated Depression and Anxiety Screening for People with Epilepsy
Lilian Coelho, MD
08:00 AM - 09:00 AM EST Abstract 1-005 - Correlation Between Depressive And Anxious Symptoms And White Matter Changes In Relatives Of People With Epilepsy
Gabriel Ferri Baltazar
08:00 AM - 09:00 AM EST Abstract 1-006 - Association of interictal EEG findings in those with concomitant epileptic seizures and PNES
Gabriela Alejo, MD
08:00 AM - 09:00 AM EST Abstract 1-008 - Improving Post-Operative Psychiatric Outcomes in Surgical Epilepsy Patients
Tandees Najimi
08:00 AM - 09:00 AM EST Abstract 1-009 - Epileptiform Discharges in Patients with Psychogenic Non-Epileptic Attacks: A Case Series
Mohamed Afify, MD
08:00 AM - 09:00 AM EST Abstract 1-011 - Investigation of anxiety, depression, and adjustment disorder in mothers of children with a seizure disorder in the Georgian population
Mariam Alavidze
08:00 AM - 09:00 AM EST Abstract 2-001 - Assessing a Novel Asynchronous EEG-Learning Curriculum via Quantitative and Qualitative Methods
Christopher Bentley Traner, MD
08:00 AM - 09:00 AM EST Abstract 2-002 - A Longitudinal Experience and Annual “Check-Ins” to Increase Resident EEG and EMG Milestone Attainment and Improve Milestone Rating Accuracy
Harry William Sutherland, MD
08:00 AM - 09:00 AM EST Abstract 2-003 - Neuropalliative Curriculum in Neurology Residency Program
Gitanjali Das, MD
08:00 AM - 09:00 AM EST Abstract 2-004 - Teaching Neurology Trainees to Provide a Terminal Diagnosis Using Objective Structured Clinical Examinations (OSCE)
Mordechai Z. Smith, MD
08:00 AM - 09:00 AM EST Abstract 2-005 - Assessing the Impact of a Multi-Modal Neuro-Ophthalmology Educational Workshop on Resident Confidence in the Neuro-Ophthalmology Examination
Jieun Kang, MD
08:00 AM - 09:00 AM EST Abstract 2-006 - An Interactive Approach to Teaching Neurology Residents about Intellectual and Developmental Disabilities (IDD): Effects of In-Person Versus Virtual Noon Conferences
Julia Sophie Frueh, MD
08:00 AM - 09:00 AM EST Abstract 3-001 - Cerebrospinal Fluid Biomarkers Associated with Intrathecal Cell Therapy in Patients with Progressive Multiple Sclerosis
Cara Kizilbash
08:00 AM - 09:00 AM EST Abstract 3-002 - Serum Natalizumab and Anti-Natalizumab Antibody Concentrations May Be Useful in Patient Management
Jane Yang, MD
08:00 AM - 09:00 AM EST Abstract 3-003 - Plasma glial fibrillary acidic protein levels correlate with unfavourable imaging measures in Radiologically Isolated Syndrome
Raphael Schneider, MD
08:00 AM - 09:00 AM EST Abstract 3-005 - Establishing Demographic and Comorbidity Based Reference Ranges for NfL and GFAP in Healthy Controls
Tyler Lee Borko, BA, EMT-IV
08:00 AM - 09:00 AM EST Abstract 3-006 - Serum NfL in MS Patients Treated with Cladribine: Course and Predictive Value
Tobias Moser
08:00 AM - 09:00 AM EST Abstract 3-007 - A Systematic Review of Epstein-Barr Virus Antibodies as Clinical Biomarkers in Multiple Sclerosis
Abigail Suprova Bose, MD
08:00 AM - 09:00 AM EST Abstract 3-008 - Identification of multiple sclerosis endophenotypes by high dimensional blood signatures associated with distinct disease trajectories
Luisa Hildegard Klotz, MD
08:00 AM - 09:00 AM EST Abstract 3-009 - Serum Neurofilament Light Chain Levels as a Biomarker of Disease Activity and Treatment Response in Patients with Progressive and Relapsing Multiple Sclerosis
Marzena Pedrini, PhD
08:00 AM - 09:00 AM EST Abstract 3-010 - Using Plasma NfL and GFAP to Monitor Response to Anti-CD20 Treatment in MS
Robert H. Gross, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 3-011 - Neurofilament Light Chain Levels and Disease Activity During Long-Term Treatment of Relapsing Multiple Sclerosis with the Bruton's Tyrosine Kinase Inhibitor Evobrutinib
Ludwig Kappos, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 3-012 - NfL as a Predictor of GdE Lesions in Patients With Relapsing Multiple Sclerosis Treated With Ozanimod in the Phase 2 RADIANCE Trial
Sarah Harris
08:00 AM - 09:00 AM EST Abstract 3-013 - Relevance of Bright Spotty Lesions (BSLs) in Neuromyelitis Optica Spectrum Disorders (NMOSD): A Case Series
Katherine Elizabeth Beard
08:00 AM - 09:00 AM EST Abstract 3-014 - Role Of Antimüllerian Hormone Levels and Neurofilament Light Chains In Family Planning In MS
Juan Pablo Cuello
08:00 AM - 09:00 AM EST Abstract 4-001 - Patient Experience with Video Telemedicine Neurology Follow-up Visits at Community Clinics
Karen A. Truitt, DO
08:00 AM - 09:00 AM EST Abstract 4-002 - Teleneurology Satisfaction during the COVID-19 Pandemic
Sheffield Sharp, Other
08:00 AM - 09:00 AM EST Abstract 4-003 - Patient Satisfaction with Teleneurology across Neurologic Conditions
Courtney Seigel
08:00 AM - 09:00 AM EST Abstract 4-004 - The Lacune of Teleneurology: Autochromatic Correction of Jaundice
Sunjeet Brar
08:00 AM - 09:00 AM EST Abstract 4-005 - Bilateral Subdural Hematoma, The Cause or Consequence
Narmada Mannem, MBBS
08:00 AM - 09:00 AM EST Abstract 4-006 - Intravenous tPA administration in patients with negative diffusion-weighted imaging (DWI) study on the MRI brain
Pradeepthi Badugu, MBBS
08:00 AM - 09:00 AM EST Abstract 4-007 - Correlation analysis of parameters of cardiointervalography and immune status in patients with ischemic stroke depending on the affected area
Nargiza Chekeeva
08:00 AM - 09:00 AM EST Abstract 5-001 - Overview of the Safety Profile from Efgartigimod Clinical Trials in Participants with Diverse IgG-Mediated Autoimmune Diseases
Kelly G. Gwathmey, MD
08:00 AM - 09:00 AM EST Abstract 5-002 - Change in Concomitant Therapies for Generalized Myasthenia Gravis in Patients Receiving Eculizumab: a Retrospective Analysis of Registry Data
Michael T. Pulley, MD, PhD
08:00 AM - 09:00 AM EST Abstract 5-003 - Comorbidities in patients with myasthenia gravis in the USA: a retrospective claims database analysis
Raj Bandaru
08:00 AM - 09:00 AM EST Abstract 5-004 - Ravulizumab for the Treatment of Generalized Myasthenia Gravis: Timing of Response
Ali A. Habib, MD
08:00 AM - 09:00 AM EST Abstract 5-005 - Investigating Autoantibody Profiles in Seronegative Myasthenia Gravis
Gianvito Masi, MD
08:00 AM - 09:00 AM EST Abstract 5-006 - Subgroup outcomes from RAISE: A randomized, Phase 3 trial of zilucoplan in generalized myasthenia gravis
Michael D. Weiss, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 5-007 - RAISE-XT: An interim analysis of safety and efficacy in an open-label extension study of zilucoplan in patients with myasthenia gravis
Miriam L. Freimer, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 5-008 - Study design and methodology of the PREVAIL trial: a phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of subcutaneous ALXN1720 in adults with generalized myasthenia gravis
James F. Howard, Jr., MD, FAAN
08:00 AM - 09:00 AM EST Abstract 5-009 - A Rare Case of Thymoma-Associated Idiopathic Inflammatory Myopathy and Myasthenia Gravis
Chelsea Schmoll, DO
08:00 AM - 09:00 AM EST Abstract 5-010 - Mortality in Mechanically Ventilated Myasthenia Gravis Adult Patients: Comparing Intravenous Immunoglobulin vs Steroids
Kranthi Kiran Mandava
08:00 AM - 09:00 AM EST Abstract 5-011 - Use of Efgartigimod in Treatment of Myasthenia Gravis Relapse after Possible Recurrence of Invasive Thymoma: A Case Report.
Elif Pinar Coskun, MD
08:00 AM - 09:00 AM EST Abstract 5-012 - Long-term Efficacy and Safety of Symptom-driven Cyclic Rozanolixizumab Treatment in Patients with Generalized Myasthenia Gravis: A Pooled Analysis of a Phase 3 Study and Two Open-label Extension Studies
John Vissing, MD
08:00 AM - 09:00 AM EST Abstract 5-013 - Ravulizumab in Adults with Generalized Myasthenia Gravis: A Sub-Analysis of the Phase 3 CHAMPION MG Study According to Chronic IVIg Use at Study Entry
Glen Frick, MD,PhD
08:00 AM - 09:00 AM EST Abstract 5-014 - Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC+ Study
James F. Howard, Jr., MD, FAAN
08:00 AM - 09:00 AM EST Abstract 5-015 - Efgartigimod Demonstrates Consistent Improvements in Generalized Myasthenia Gravis Patients of Shorter Disease Duration
Edward Brauer
08:00 AM - 09:00 AM EST Abstract 5-016 - Safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of subcutaneous and intravenous ALXN1720 in healthy volunteers: a phase 1, randomized, double-blind, placebo-controlled, single and multiple ascending dose study
Stephan Ortiz, PhD
08:00 AM - 09:00 AM EST Abstract 5-017 - Dose Selection and Clinical Development of Efgartigimod PH20 Subcutaneous in Patients with Generalized Myasthenia Gravis
Jenna Casey
08:00 AM - 09:00 AM EST Abstract 5-018 - Nipocalimab Dose Selection for A Phase 3 Study in Adult Patients with Generalized Myasthenia Gravis
Yaowei Zhu, PhD
08:00 AM - 09:00 AM EST Abstract 5-019 - Post COVID-19 Myasthenia Gravis
Nathaniel Pendleton Rogers, Jr., MD
08:00 AM - 09:00 AM EST Abstract 5-020 - Myasthenia Gravis Activities of Daily Living (MG-ADL) Response to Eculizumab Treatment in Patients from the Generalized Myasthenia Gravis Registry
Ericka P. Greene, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 5-021 - Insomnia Symptoms Trajectories and increased risk of Stroke: A Prospective Cohort Study
Wendemi Sawadogo
08:00 AM - 09:00 AM EST Abstract 5-022 - Impact of Insurance on Acute Stroke Care Cost: A mediation analysis
Andrew Mebane Southerland, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 5-023 - Effect of SARS-CoV-2 Pandemic on Trends in Stroke Hospitalizations and Associated Risk Factors in Non-SARS-CoV-2 Infection Patients
Mohsen Ahmed
08:00 AM - 09:00 AM EST Abstract 5-024 - Data in brief: Factors associated with in-patient admission among stroke patients
Jared Craig Wolfe
08:00 AM - 09:00 AM EST Abstract 5-026 - Substance Use, Demographics, and Other Medical Diagnoses That Increase Readmission Rates After Stroke
Christina Istrate, MD
08:00 AM - 09:00 AM EST Abstract 5-027 - Association Between TBI Exposure and Multiple Sclerosis Among Post-9/11 Era Veterans
Mary Jo Pugh, PhD, RN, FAAN
08:00 AM - 09:00 AM EST Abstract 5-028 - Addressing The Traumatic Brain Injury Crisis In Thailand: Analysis Of National Access To Neurosurgical Facilities Utilizing Geospatial Mapping
Arnav Mahajan
08:00 AM - 09:00 AM EST Abstract 5-029 - Sex Differences in Characteristics and Outcomes of Patients with Todd’s Paralysis; An Analysis From 11,175 Cases in the United States
Shaheen Sombans, MBBS
08:00 AM - 09:00 AM EST Abstract 5-030 - Survival Analysis Methods in Natural History Studies
Alex Berger, BS
08:00 AM - 09:00 AM EST Abstract 5-031 - Regional Epidemiology of Status Epilepticus: Determinants for Healthcare Cost and Outcome in Central New York
Yung-Tian Anjolie Gau, MD, PhD
08:00 AM - 09:00 AM EST Abstract 5-032 - Predictors of No-show in Neurology clinics
Thirumalaivasan Dhasakeerthi, MBBS
08:00 AM - 09:00 AM EST Abstract 6-001 - Cdk5 inhibition in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis suppresses neurodegeneration and extends survival.
Ahwon Kim, MD
08:00 AM - 09:00 AM EST Abstract 6-002 - Hexanucleotide repeat expansions in C9orf72 alter microglial responses and prevent a coordinated glial reaction in ALS
Pegah Masrori, MD
08:00 AM - 09:00 AM EST Abstract 6-003 - RACK1 Knockdown is a Potential Therapeutic Target in ALS and FTLD-TDP
Neil R. Cashman, MD
08:00 AM - 09:00 AM EST Abstract 6-004 - Aqueously diffusible RNA-bound amyloid-ß aggregates in Alzheimer disease brain
Andrew Stern, MD
08:00 AM - 09:00 AM EST Abstract 6-005 - Single-cell RNA analysis reveals cell-specific increases in SUR1-related pathway activity with age in murine brain.
Zujian Xiong, MD,PhD
08:00 AM - 09:00 AM EST Abstract 6-006 - Protection against toxic amyloid-beta oligomers by PMN310, a monoclonal antibody rationally designed for greater therapeutic potency in Alzheimer’s disease
Johanne M. Kaplan, PhD
08:00 AM - 09:00 AM EST Abstract 6-007 - A Lipopolysaccharide Mouse Model Mirrors Neuroinflammatory Transcriptional Signatures of Human AD, and the Glucagon-Like Peptide-1 Receptor Agonist Semaglutide Attenuates Neuroinflammation in this Model
Christian Wichmann
08:00 AM - 09:00 AM EST Abstract 6-008 - Microbiota-derived SCFAs Promote Chronic Neurogenesis and Anti-inflammatory Gene Expression after Traumatic Brain Injury
Zujian Xiong, MD,PhD
08:00 AM - 09:00 AM EST Abstract 6-009 - Optogenetic activation of basal forebrain cholinergic neurons improves interval timing performance in rodents
Qiang Johnson Zhang, MD
08:00 AM - 09:00 AM EST Abstract 6-010 - Assessing the Co-Chaperone and Synaptic Protein DNAJC5 as a Therapeutic Target in Alzheimer’s Disease
Matthew James Rosene, PhD
08:00 AM - 09:00 AM EST Abstract 7-001 - Neuroprognostication After Out of Hospital Asystole Cardiac Arrest
Trilok Stead
08:00 AM - 09:00 AM EST Abstract 7-002 - Predictors of Good Neurologic Outcome After Pulseless Electrical Activity
Latha Ganti, MD, MS, MBA, FACEP
08:00 AM - 09:00 AM EST Abstract 7-004 - Isolated Brainstem Death is Rare and is Associated with Infratentorial Stroke Among Patients Suspected of Death by Neurologic Criteria
Joel Neves Briard, MD
08:00 AM - 09:00 AM EST Abstract 7-005 - Efficacy of the Implementation of Brain Herniation Codes at a Tertiary Medical Center
Eunice Jiyoung Lee, MD
08:00 AM - 09:00 AM EST Abstract 7-006 - Eye Movement and Coma Recovery after Cardiac Arrest
Michael Francis Maimon Cronin
08:00 AM - 09:00 AM EST Abstract 8-001 - A case report of resolving an uncertain variant in CHRN1B as pathogenic leading to Congenital Myasthenic Syndrome type 2C.
Zurisadai Gonzalez Castillo, MD
08:00 AM - 09:00 AM EST Abstract 8-002 - Triple M Syndrome with Triple Seronegative Myasthenia Gravis presenting as a Non-ST Elevation Myocardial Infarction
Octavio Carranza-Renteria, MD
08:00 AM - 09:00 AM EST Abstract 8-004 - Clinical Experience With Efgartigimod For Treatment Of Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis
Nakul Katyal
08:00 AM - 09:00 AM EST Abstract 8-005 - Malignant Ectopic Cervical Thymoma in Myasthenia Gravis: A Case Report
Shima Zargar, MD
08:00 AM - 09:00 AM EST Abstract 8-006 - Efgartigimod for Pembrolizumab-induced Myasthenia Gravis Refractory to Standard Therapy
Zufe Rizvi, MD
08:00 AM - 09:00 AM EST Abstract 8-007 - The impact of Myasthenia Gravis antibody status on pregnancy and neonatal outcomes
Mariam Al Hussona, MB BCh BAO
08:00 AM - 09:00 AM EST Abstract 8-008 - Acquired Rippling Muscle Disease with Acetylcholine Receptor Antibodies
Thapat Wannarong, MD
08:00 AM - 09:00 AM EST Abstract 8-009 - Characterization of Early Adopters of Efgartigimod for gMG
Emma McFadden, PhD
08:00 AM - 09:00 AM EST Abstract 8-010 - Iron Metabolism Patterns in Non-anemic Myasthenia Gravis Patients: A Cross-sectional and Follow-up Study
Ke Li, MD
08:00 AM - 09:00 AM EST Abstract 8-011 - Benefit of Neuromuscular Ultrasound on Patient Management and Outcomes
Raed Gasemaltayeb, MD
08:00 AM - 09:00 AM EST Abstract 8-012 - Utility of Diagnostic Neuromuscular Ultrasound in Unrevealing Electrodiagnostic Studies: Case Series
Eonjung Kim, MD
08:00 AM - 09:00 AM EST Abstract 8-013 - Four Looks to a Gene
Narges Rahimi, MD
08:00 AM - 09:00 AM EST Abstract 8-015 - Validation of the Toronto Cramp Impact Index (TCII) for Assessment of Muscle Cramps
Hans D. Katzberg, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 9-001 - Orbital Myositis Presenting as a Late Immune-Related Adverse Event Four Months After Stopping Immune Checkpoint Inhibitor
Mohammad Dibs, MD
08:00 AM - 09:00 AM EST Abstract 9-004 - A Case of Neural Integrator Failure in Vitamin B1 Deficiency.
Hongying Chen, MB BCh BAO
08:00 AM - 09:00 AM EST Abstract 9-006 - Horner’s Syndrome as an Atypical Presentation of Neuroborreliosis: A Case Report and Review of Literature
Sarah Bou Reslan, MD
08:00 AM - 09:00 AM EST Abstract 9-007 - A Rare Case of Bilateral Optic Perineuritis, Scleritis and Uveitis in a Pediatric Patient Following Influenza Vaccination
Nathaniel Gray Wooten, MD
08:00 AM - 09:00 AM EST Abstract 9-008 - Bilateral Ischemic Optic Neuropathy as the First Manifestation of Severe Anemia
Sayyeda Zahra, MD
08:00 AM - 09:00 AM EST Abstract 9-010 - When vision loss is beyond cataract: a case of fatal neurodegenerative disease
Khawla M. Abusamra, MBBS
08:00 AM - 09:00 AM EST Abstract 9-011 - Visual hallucinations. More than just a psychiatric problem.
Muhammad Sulman Bhatti, MD
08:00 AM - 09:00 AM EST Abstract 9-012 - Curious Cases of Painful Ophthalmoplegia
Keshav Jayeshbhai Shah, MD
08:00 AM - 09:00 AM EST Abstract 10-001 - Pitfalls in the diagnosis of Cryptococcal Meningoencephalitis.
Yash Nene, MBBS
08:00 AM - 09:00 AM EST Abstract 10-002 - Bruton Tyrosine Kinase Inhibitor Associated Cryptococcal Meningitis Manifesting as Stroke
Michael A Perez, MD
08:00 AM - 09:00 AM EST Abstract 10-003 - A Case of Brainstem Cryptococcoma Causing Pontine Stroke in an Immunocompetent Male
Iffat Jabeen, MD
08:00 AM - 09:00 AM EST Abstract 10-004 - Cryptococcal Cerebellitis In the Setting of Fingolimod Use for Multiple Sclerosis: Atypical Clinical Presentation of Dystonia and Imaging Finding Mimicking Subacute Ischemic Stroke
Raman Singh, MD, MBBS
08:00 AM - 09:00 AM EST Abstract 10-005 - Cryptococcal Meningoencephalitis and Immune Reconstitution Inflammatory Syndrome in a patient on Tocilizumab Therapy: A Case Report
Nina Navalkar, MD
08:00 AM - 09:00 AM EST Abstract 10-006 - Atypical Presentation of Nocardia Brainstem Abscess: A Case Report
Sathvik S Shastry, MD
08:00 AM - 09:00 AM EST Abstract 10-007 - Bacterial Meningitis, Streptococcus Suis Isolate: A Case Series
Wilgee Eila Sun Abbot, MD
08:00 AM - 09:00 AM EST Abstract 11-001 - A Double-Blind, Sham Controlled Study of Transcranial Photobiomodulation (PBM) in Parkinsons Disease
Geoffrey Kenneth Herkes, PhD, FRACP, MBBS
08:00 AM - 09:00 AM EST Abstract 11-002 - Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease: ADAPT-PD clinical trial methodology and early data
Todd Herrington, MD
08:00 AM - 09:00 AM EST Abstract 11-003 - Foslevodopa/foscarbidopa Subcutaneous Infusion Maintains Similar Levodopa Exposure to Levodopa-Carbidopa Intestinal Gel Delivered to the Jejunum when Infused for 24-hours
Matthew Rosebraugh, PhD
08:00 AM - 09:00 AM EST Abstract 11-004 - Design and Baseline characteristic of Phase II clinical trial of allogeneic bone marrow-derived Mesenchymal Stem Cells as a disease-modifying therapy for idiopathic Parkinson’s disease
Mya C. Schiess, MD
08:00 AM - 09:00 AM EST Abstract 11-005 - Randomized, waitlist-controlled trial of KICK OUT PD: Parkinson’s Disease-specific karate yields high adherence and improved quality of life
Joshua Chodosh, MD
08:00 AM - 09:00 AM EST Abstract 11-006 - Integrated safety summary from Phase 3 clinical trials of IPX203, an extended-release carbidopa-levodopa formulation, in Parkinson disease
Hubert H. Fernandez, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 11-007 - Reducing a-Synuclein in Human CSF; An Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEDI1341, an a-Synuclein-specific antibody, in Healthy Volunteers and Parkinson’s Disease Patients
Craig Shering, Other
08:00 AM - 09:00 AM EST Abstract 11-008 - Safety, Tolerability, And Efficacy Of NE3107 From A Phase 2, Double-Blind, Placebo-Controlled Study In Levodopa/Carbidopa-Treated Patients With Parkinson's Disease
Nilab Osman, MD
08:00 AM - 09:00 AM EST Abstract 11-009 - Racial and Ethnic Disparities in Access to Huntington’s Disease (HD) care in North America: Analysis using the ENROLL-HD dataset
Adys Mendizabal, MD
08:00 AM - 09:00 AM EST Abstract 11-010 - Chorea Severity Change Over Time in Huntington Disease and by Huntington Disease Stage
Nayla Chaijale
08:00 AM - 09:00 AM EST Abstract 11-011 - Randomized Trial of Telegenetic Counseling for Gene Testing in Huntington’s Disease
Deborah Hall, MD, PhD, FAAN
08:00 AM - 09:00 AM EST Abstract 11-012 - The Risk of Depression in a Large Huntington Disease Population Compared With Controls: Analysis of the Enroll-HD Registry Data
Nayla Chaijale
08:00 AM - 09:00 AM EST Abstract 11-013 - Melatonin for Huntington Disease (HD) Gene Carriers with HD-Related Sleep Disturbance - a Pilot Study
Jorge Eduardo Patino Murillas, MD
08:00 AM - 09:00 AM EST Abstract 11-014 - Prevalence of Neurocognitive Disorder in a Pre-manifest Huntington’s disease Cohort
Luis Alberto Sierra, Jr.
08:00 AM - 09:00 AM EST Abstract 11-015 - Molecular Gene Expression Analysis of Medium Spiny Neurons in Huntington’s Disease
Evan El-Halawani
08:00 AM - 09:00 AM EST Abstract 11-016 - Investigating the Effects of Brain Cholesterol Metabolism Using CYP46A1 Gene Therapy in Subjects with Huntington’s Disease
Meredith Schultz, MD
08:00 AM - 09:00 AM EST Abstract 12-001 - “Klüver-Bucy syndrome as a complication of COVID-19”
Nigar Dargah-Zada, MD
08:00 AM - 09:00 AM EST Abstract 12-003 - Cerebral amyloid angiopathy-related inflammation (CAARI) and HHV-6 positivity: A case report of a treatment dilemma and a possible relationship
Anas Alshawa, MD
08:00 AM - 09:00 AM EST Abstract 12-004 - A Scoping Review of Functional Neurological Disorder in Sexual and Gender Minority People
Valeria Roldan
08:00 AM - 09:00 AM EST Abstract 12-005 - Establishing the relationship between ADHD and emotional facial expression recognition deficit: a systematic review
Maria Daniela Olaya Galindo, MD
08:00 AM - 09:00 AM EST Abstract 12-006 - A Survey of Virtual Reality Interventions for Autistic Spectrum Disorder Therapy: A Neuroscience Perspective
Dana Allison
08:00 AM - 09:00 AM EST Abstract 12-007 - Identifying Key Patterns of Social and Structural Determinants of Health and Their Association with Dementia Risk in a Population-Based Study of Cognitive Aging
Maria Vassilaki, MD, PhD
08:00 AM - 09:00 AM EST Abstract 12-008 - CD5 knockout modulates effects of alcohol consumption in mouse models
Alfred Biagio Amendolara, Jr.
08:00 AM - 09:00 AM EST Abstract 12-009 - Norepinephrine Regulates Spatial Memory Consolidation Using Barnes Maze in Male, but Not Female Rats
Serena Simpson
08:00 AM - 09:00 AM EST Abstract 12-010 - Prevalence, demographics and etiologies of early-onset dementia in Brazil: a retrospective cohort
Joao Vitor Mahler Ferreira Oliveira
08:00 AM - 09:00 AM EST Abstract 13-001 - Evaluation of Sleep Parameters with Polysomnography and Multiple Sleep Latency Test in Cirrhotic Patients with Daytime Sleepiness
Kadriye Agan
08:00 AM - 09:00 AM EST Abstract 13-002 - Untreated Moderate-to-Severe Sleep-Related Breathing Disorders Are Associated with Increased Frequency of Episodes of Autonomic Dysreflexia during Sleep in Individuals with Subacute or Chronic Spinal Cord Injury: A Prospective Cross-Sectional Study.
Julio C. Furlan, MD,PhD,MBA,MSc,FAAN
08:00 AM - 09:00 AM EST Abstract 13-003 - Brain Age Prediction based on Sleep EEG in Shift Workers
Su Jung Choi, PhD,RN
08:00 AM - 09:00 AM EST Abstract 13-004 - Sleep Duration is Associated with Clinically Silent Brain Injury in Middle-Aged Persons without Stroke
Santiago Clocchiatti-Tuozzo
08:00 AM - 09:00 AM EST Abstract 13-005 - Insomnia and Post Acute Sequelae of COVID-19 in an outpatient neurology cohort
Sherry Fung
Faculty Disclosures
Shruti K. Jaiswal, MBBS Mrs. Jaiswal has nothing to disclose.
Claudia Talero-Gutierrez Dr. Talero-Gutierrez has nothing to disclose.
Rinat Ribalov Rinat Ribalov has received personal compensation for serving as an employee of TEVA.
Ciaran Nannery, MBBS Dr. Nannery has nothing to disclose.
Perrin A. Pleninger, MD, FAAN Dr. Pleninger has nothing to disclose.
Brittany Paige Nelson, Other Mrs. Nelson has nothing to disclose.
Sujata P. Thawani, MD Dr. Thawani has nothing to disclose.
Ronald C. Petersen, PhD, MD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc.. Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Inc.. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Nicole Rosendale, MD Dr. Rosendale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. The institution of Dr. Rosendale has received research support from American Academy of Neurology. The institution of Dr. Rosendale has received research support from NIH StrokeNet Fellowship. Dr. Rosendale has received publishing royalties from a publication relating to health care.
Kavita Nair, PhD, FAAN Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Healthcare. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS.
John Corboy, MD, FAAN Dr. Corboy has received personal compensation for serving as an employee of U of Coloado. Dr. Corboy has received personal compensation for serving as an employee of Rocky Mountain MS Center. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mylan. Dr. Corboy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Mylan. The institution of Dr. Corboy has received research support from MedDay. The institution of Dr. Corboy has received research support from Novartis. The institution of Dr. Corboy has received research support from NMSS. The institution of Dr. Corboy has received research support from PCORI. The institution of Dr. Corboy has received research support from EMD Serono.
Ariane Lewis, MD, FAAN Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Sunjeet Brar Miss Brar has nothing to disclose.
Anas Alshawa, MD Dr. Alshawa has nothing to disclose.
Mariam Alavidze Miss Alavidze has nothing to disclose.
Craig Shering, Other Dr. Shering has received personal compensation for serving as an employee of AstraZeneca. An immediate family member of Dr. Shering has received personal compensation for serving as an employee of eResearch Technology Inc. Dr. Shering has stock in AstraZeneca. Dr. Shering has received intellectual property interests from a discovery or technology relating to health care.
Vern C. Juel, MD, FAAN Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accordant Health Services. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network.
Raphael Schneider, MD Dr. Schneider has nothing to disclose.
Charles Pyke No disclosure on file
Stefan Sillau The institution of Stefan Sillau has received research support from Alzheimer's Association. The institution of Stefan Sillau has received research support from Hewitt Family Foundation; State of Colorado. The institution of Stefan Sillau has received research support from PCORI. The institution of Stefan Sillau has received research support from NINR. The institution of Stefan Sillau has received research support from Michael J. Fox Foundation. The institution of Stefan Sillau has received research support from Department of Defense. The institution of Stefan Sillau has received research support from Colorado Department of Public Health and Environment. The institution of Stefan Sillau has received research support from Benign Essential Blepharospasm Research Foundation. Stefan Sillau has a non-compensated relationship as a Statistician with Novartis that is relevant to AAN interests or activities. Stefan Sillau has a non-compensated relationship as a Statistician with Biogen that is relevant to AAN interests or activities.
Girardin Jean-Louis No disclosure on file
Tarek Emran Ali, MBBS Dr. Ali has nothing to disclose.
Emma Yellin, MD Dr. Yellin has nothing to disclose.
Samir Philip Macwan, MD Dr. Macwan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion,Argenx,Catalyst,Kabafusion, UCB. Dr. Macwan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie,Alexion,Argenx,Biohaven,Catalyst,Grifols,Supernus. The institution of Dr. Macwan has received research support from Alexion, Disimmune Disease Foundation .
Feyza Gunduz, MD Dr. Gunduz has nothing to disclose.
Jeffrey L. Bennett, MD, PhD, FAAN Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reistone Bio. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ImCyse. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Podoll. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Patterson. The institution of Dr. Bennett has received research support from Novartis. The institution of Dr. Bennett has received research support from Alexion. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Jiwon Oh, MD, FAAN Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from Roche.
Patrick Landazuri, MD, FAAN Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Federal Public Defender - District of Kansas. Dr. Landazuri has received publishing royalties from a publication relating to health care.
Arielle Marisa Kurzweil, MD, FAAN Dr. Kurzweil has nothing to disclose.
Jorge Eduardo Patino Murillas, MD Dr. Patino Murillas has nothing to disclose.
James E. Siegler, III, MD Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various medicolegal cases. The institution of Dr. Siegler has received research support from Viz.ai.
Joseph S Neimat, MD Dr. Neimat has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Monteris, Abbott.
Ian Ball, MD Dr. Ball has nothing to disclose.
Sonia Brucki Sonia Brucki has nothing to disclose.
Sophie Steeland, PhD,Other Mrs. Steeland has nothing to disclose.
Alixandria Trombley, Other Mrs. Trombley has nothing to disclose.
Abigail Suprova Bose, MD Dr. Bose has nothing to disclose.
Nora Buenger, MD Dr. Buenger has nothing to disclose.
Anna Castillo Anna Castillo has nothing to disclose.
Nizar Souayah, MD, FAAN Dr. Souayah has received publishing royalties from a publication relating to health care.
Ace Adamson, PhD Dr. Adamson has nothing to disclose.
Kazim Jaffry Mr. Jaffry has nothing to disclose.
Lawrence J. Hirsch, MD, FAAN Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accure. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rafa Laboratories, Ltd. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a speaker with UCB.
David M. Greer, MD, FAAN Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. The institution of Dr. Greer has received research support from Becton, Dickinson and Company. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care.
Andrew Mebane Southerland, MD, FAAN Dr. Southerland has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Plaintiffs and Defense Cases related to Stroke and Vascular Neurology.. The institution of Dr. Southerland has received research support from Diffusion Pharmaceuticals. The institution of Dr. Southerland has received research support from American Heart Association. The institution of Dr. Southerland has received research support from National Science Foundation. The institution of Dr. Southerland has received research support from NIH. The institution of Dr. Southerland has received research support from Abbvie Pharmaceuticals, Inc.. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care.
Z Paige L'Erario, MD Dr. L'Erario has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ohio State University, University of Colorado, Sacred Heart University, The LOFT LGBT Community Center, Oregon Stroke Conference, Child Neurology Society. Dr. L'Erario has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Weiss Law. Dr. L'Erario has received publishing royalties from a publication relating to health care.
Robert H. Gross, MD, FAAN Dr. Gross has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for AP Expert Group.
Guido Jose Falcone, MD The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Lilian Coelho, MD Dr. Coelho has nothing to disclose.
Debarup Das, MD,MBBS Dr. Das has nothing to disclose.
Li’an Hou No disclosure on file
Thomas M. Hyde, MD, PhD Dr. Hyde has received personal compensation for serving as an employee of Lieber Institute for Brain Development. The institution of Dr. Hyde has received research support from National Institutes of Health.
Benjamin Van Hoorick, MD Dr. Van Hoorick has received personal compensation for serving as an employee of argenx.
Marc Dinkin, MD Dr. Dinkin has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for WILSON ELSER MOSKOWITZ EDELMAN & DICKER LLP. Dr. Dinkin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Rehabilitation Alternative Services, Inc.. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for AMFS / Medical Experts Nationwide. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bekman, Marder, Hopper, Malarkey & Perlin, L.L.C.. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Northwestern Mutual. Dr. Dinkin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Young Conaway Stargatt & Taylor. Dr. Dinkin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Young and Conway . Dr. Dinkin has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Luks, Santiello.
Deborah Hall, MD, PhD, FAAN Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Neurocrine. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from SAGE. The institution of Dr. Hall has received research support from NIH.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia. Dr. Balcer has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for North American Neuro-Ophthalmology Society.
Neepa J. Patel, MD Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott Laboratories. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Pharmaceuticals. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticals.
Ahwon Kim, MD Dr. Kim has nothing to disclose.
Hannah Shapiro, MD Dr. Shapiro has nothing to disclose.
Krishna Nalleballe, MD, FAAN Dr. Nalleballe has nothing to disclose.
Matthew Kent Mr. Kent has nothing to disclose.
Melanie Guenette Melanie Guenette has nothing to disclose.
Shahram Attarian, MD, PhD Prof. Attarian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI, Pfizer LFB, Alnylam Biogen . Prof. Attarian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SANOFI, Biogen. The institution of Prof. Attarian has received research support from National Institut of Health .
Ananya Saraph Miss Saraph has nothing to disclose.
Carolina Cuello-Oderiz, MD Dr. Cuello-Oderiz has nothing to disclose.
Ali Seifi Ali Seifi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi. Ali Seifi has received intellectual property interests from a discovery or technology relating to health care.
Jose Antonio Robles-Zurita, PhD Dr. Robles-Zurita has received personal compensation for serving as an employee of HCD Economics. Dr. Robles-Zurita has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for HCD Economics.
Laura Elena Paul, MD Dr. Paul has nothing to disclose.
John E. Paddock, MD Dr. Paddock has nothing to disclose.
Raul Juntas-Morales No disclosure on file
Shulian Shang Shulian Shang has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Shulian Shang has received stock or an ownership interest from Alexion Pharmaceuticals.
Nareen Sadik, Other Miss Sadik has received personal compensation for serving as an employee of Wayne State University .
Susan T. Herman, MD, FAAN The institution of Dr. Herman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for National Association of Epilepsy Centers. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Treatment Options in Neurology. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Herman has received research support from Epilepsy Foundation; Epilepsy Learning Healthcare System. The institution of Dr. Herman has received research support from CREMedical. The institution of Dr. Herman has received research support from NIH/NINDS. The institution of Dr. Herman has received research support from Marinus. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as a Medical Director, Neurodiagnostics Program with Laboure College. Dr. Herman has a non-compensated relationship as a Professional Advisory Board member with Epilepsy Foundation that is relevant to AAN interests or activities.
Srikanth Muppidi, MD, FAAN Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Lidia Maria Veras Rocha Moura, MD, PhD, MPH, FAAN Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for eNova. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Foundation. The institution of Dr. Moura has received research support from NIH-NIA - 1K08AG053380-01A1. The institution of Dr. Moura has received research support from NIH-NIA 5R01AG062282-02 . The institution of Dr. Moura has received research support from NIH-NIA 2P01AG032952-11 . The institution of Dr. Moura has received research support from NIH- NIA 3R01AG062282-03S1 . The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America .
Jonathan Graff-Radford, MD Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai.
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Sasha Alick-Lindstrom, MD, FAAN, FACNS,FAES Dr. Alick-Lindstrom has nothing to disclose.
Aileen Antonio, MD, FAAN Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cochrane. Dr. Antonio has received research support from AAN PALF. The institution of Dr. Antonio has received research support from Trinity Health Foundation. The institution of Dr. Antonio has received research support from AAN IDEAS Grant. The institution of Dr. Antonio has received research support from Saint Mary's Foundation. The institution of Dr. Antonio has received research support from Saint Mary's Foundation .
Jeffrey Dewey, MD Dr. Dewey has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for United States.
Jill L. Ostrem, MD, FAAN Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Ostrem has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz . Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Superness. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcureX. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Ostrem has received research support from Neuroderm. The institution of Dr. Ostrem has received research support from Boston Scientific. The institution of Dr. Ostrem has received research support from Medtronic. The institution of Dr. Ostrem has received research support from Rune.
Michael G. Benatar, MBChB, DPhil, FAAN Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
Ima M. Ebong, MD The institution of Dr. Ebong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB.
Judith Silverman Judith Silverman has received personal compensation for serving as an employee of Bill & Melinda Gates Foundation.
Rebecca Seale Ms. Seale has stock in Johnson & Johnson.
Jai Jai Shankar Jai Jai Shankar has nothing to disclose.
Jonathan Ross Galli, MD Dr. Galli has nothing to disclose.
Tahseen Mozaffar, MD, FAAN Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis Therapeutics. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/ Ra Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maze Therapeutics. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institutes of Health. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neuromuscular Disease Foundation. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi-Genzyme. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Spark Therapeutics. The institution of Dr. Mozaffar has received research support from Audentes Therapeutics. The institution of Dr. Mozaffar has received research support from Cartesian. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Braedon Kirkpatrick, Other Mr. Kirkpatrick has nothing to disclose.
Amanda Lee Piquet, MD, FAAN The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. The institution of Dr. Piquet has received personal compensation in the range of $0-$499 for serving as a Consultant for EMD Serono. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Novartis. The institution of Dr. Piquet has received research support from Abbvie. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
Nicholas Joseph Silvestri, MD, FAAN Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Strongbridge. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Silvestri has received publishing royalties from a publication relating to health care.
Samuel A. Frank, MD, FAAN Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Triplet Therapeutics.
David L. Perez, MD, FAAN Dr. Perez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley: Brain and Behavior. The institution of Dr. Perez has received research support from NIH. The institution of Dr. Perez has received research support from Sidney R. Baer Jr. Foundation. Dr. Perez has received publishing royalties from a publication relating to health care.
Nargiza Chekeeva Nargiza Chekeeva has nothing to disclose.
Kevin O'Connor Kevin O'Connor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Kevin O'Connor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Kevin O'Connor has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viela Bio. Kevin O'Connor has stock in Cabaletta.
Martijn Beudel, MD,PhD Dr. Beudel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic .
Katherine Elizabeth Beard Miss Beard has nothing to disclose.
Yogeshwaree Ramphul, MD Dr. Ramphul has nothing to disclose.
Olivia Mattner, DO Dr. Mattner has nothing to disclose.
Yvette Bordelon, MD The institution of Dr. Bordelon has received research support from Neuraly. The institution of Dr. Bordelon has received research support from AbbVie.
Hafiz Khan, PhD Dr. Khan has nothing to disclose.
Ying Li Ying Li has received personal compensation for serving as an employee of EMD Serono.
Luisa Hildegard Klotz, MD Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Klotz has received research support from Immunic AG. The institution of Dr. Klotz has received research support from Merck.
Myrka Raquel Torres-Melendez, MD Dr. Torres-Melendez has nothing to disclose.
Adys Mendizabal, MD Dr. Mendizabal has received research support from Huntington's Disease Society of America.
Scott C. Steffensen, PhD Dr. Steffensen has stock in Syzygy Innovations, LLC. Dr. Steffensen has received intellectual property interests from a discovery or technology relating to health care.
Daniela Brenda Renedo, MD Dr. Renedo has nothing to disclose.
Raman Singh, MD, MBBS Dr. Singh has nothing to disclose.
Anna Secher, PhD Dr. Secher has received personal compensation for serving as an employee of Novo Nordisk. An immediate family member of Dr. Secher has received personal compensation for serving as an employee of Novo Nordisk. Dr. Secher has stock in Novo Nordisk.
Helen Azevedo, MD Helen Azevedo has nothing to disclose.
Bharti Manwani, MD Dr. Manwani has nothing to disclose.
Alison Wilkinson-Smith, PhD Dr. Wilkinson-Smith has nothing to disclose.
Artur Druzdz, PhD Dr. Druzdz has nothing to disclose.
Sarah Bou Reslan, MD Dr. Bou Reslan has nothing to disclose.
Sharlet Anderson, PhD Dr. Anderson has nothing to disclose.
Jana Podhorna, MD,PhD Dr. Podhorna has received personal compensation for serving as an employee of argenx. Dr. Podhorna has stock in argenx.
Saud A. Sadiq, MD, MB, FAAN Dr. Sadiq has nothing to disclose.
Shane English Shane English has nothing to disclose.
Alysia Martins, Other Miss Martins has nothing to disclose.
Friedemann Paul The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe PC (MTPC). The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aarhus University. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CELGENE. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACRELION. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viela Bio. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizter. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer.
Todd Herrington, MD Dr. Herrington has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic, Inc. Dr. Herrington has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MarvelBiome. Dr. Herrington has received personal compensation in the range of $0-$499 for serving as an Expert Witness for CRICO. The institution of Dr. Herrington has received research support from NIH/NINDS (K23NS099380).
Brittany Jay Duncan Mrs. Duncan has nothing to disclose.
Narges Rahimi, MD Dr. Rahimi has nothing to disclose.
Pushpa Narayanaswami, MBBS, MD, FAAN Dr. Narayanaswami has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx USA. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve, Wiley. Dr. Narayanaswami has stock in Moderna. Dr. Narayanaswami has stock in Dr. Reddys laboratories. Dr. Narayanaswami has stock in Pfizer. Dr. Narayanaswami has stock in Viatris. Dr. Narayanaswami has stock in Doximity. The institution of Dr. Narayanaswami has received research support from Alexion. Dr. Narayanaswami has a non-compensated relationship as a Member, Medical and Scientific Advisory Board with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Narayanaswami has a non-compensated relationship as a Member, Board of Directors with AANEM that is relevant to AAN interests or activities.
Michael Seiberl Michael Seiberl has nothing to disclose.
Alfred Biagio Amendolara, Jr. Mr. Amendolara has nothing to disclose.
Kamleshun Ramphul, MD Dr. Ramphul has nothing to disclose.
Laura Myers Laura Myers has nothing to disclose.
Adreesh Mukherjee, MD Dr. Mukherjee has nothing to disclose.
Olga Vsevolodivna Steinberg Mrs. Steinberg has nothing to disclose.
Anne Berndl Dr. Berndl has nothing to disclose.
Elina Zakin, MD The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology.
Arlene Ng, MD,PhD Dr. Ng has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Unilab. Dr. Ng has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Menarini. Dr. Ng has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Torrent Pharma.
Maram Shati AL Anbar, Jr., MD Dr. AL Anbar has nothing to disclose.
Romana Lowcock, Other The institution of Mrs. Lowcock has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for UCB.
Dhivyaa Rajasundaram, PhD Dr. Rajasundaram has nothing to disclose.
Afaaq Ahmed Mr. Ahmed has nothing to disclose.
Anishee Shah Undavia, MD Dr. Undavia has nothing to disclose.
Yingkai Li, MD, PhD The institution of Dr. Li has received research support from Myasthenia Gravis Foundation of America.
Joseph Polex-Wolf, PhD Dr. Polex-Wolf has received personal compensation for serving as an employee of Novo Nordisk A/S.
Eric Engebretson Mr. Engebretson has nothing to disclose.
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Stine Normann Hansen, PhD Dr. Hansen has received personal compensation for serving as an employee of Neumirna Therapeutics. Dr. Hansen has received intellectual property interests from a discovery or technology relating to health care.
Sanghamitra Laskar, MD Dr. Laskar has nothing to disclose.
Mary Russo Mary Russo has nothing to disclose.
Raed Gasemaltayeb, MD Dr. Gasemaltayeb has nothing to disclose.
Hosung Kim, PhD Prof. Kim has nothing to disclose.
Alexis Turgeon Alexis Turgeon has nothing to disclose.
Simon Kayyal, MD Dr. Kayyal has nothing to disclose.
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Salma Yahya Bashayreh, MD Dr. Bashayreh has nothing to disclose.
Chad Aldridge Chad Aldridge has nothing to disclose.
Jeffrey Waugh, MD, PhD, FAAN Dr. Waugh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Two independent law firms. The institution of Dr. Waugh has received research support from AAN.
Roxana Maria Dragomir, MD Dr. Dragomir has nothing to disclose.
Elodie Hainque, MD,PhD Dr. Hainque has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Hainque has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Medtronic.
Brianna Jean Sennott, MD An immediate family member of Dr. Sennott has received personal compensation for serving as an employee of Abbott Laboratories.
Kan Ding, MD The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Kelly Sloane, MD The institution of Dr. Sloane has received research support from National Center for Advancing Translational Sciences of the National Institutes of Health: KL2TR001879.
Dennis J. Selkoe, MD, FAAN Dr. Selkoe has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Prothena Biosciences. Dr. Selkoe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI.
Saskia Bresch, MD Dr. Bresch has nothing to disclose.
Maysaa Merhi Basha, MD Dr. Basha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Cara Kizilbash Miss Kizilbash has nothing to disclose.
Kogul Arumaithurai, MD Dr. Arumaithurai has nothing to disclose.
Enric Monreal Laguillo Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers Squibb.
Chindo Bala Mallum, MD Dr. Mallum has nothing to disclose.
Julio C. Furlan, MD,PhD,MBA,MSc,FAAN The institution of Dr. Furlan has received research support from Wings for Life Spinal Cord Research Foundation. The institution of Dr. Furlan has received research support from Craig H Neilsen Foundation. The institution of Dr. Furlan has received research support from Ontario Neurotrauma Foundation. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from J P Bickell Foundation. The institution of Dr. Furlan has received research support from Praxis Spinal Cord Institute. The institution of Dr. Furlan has received research support from Cervical Spine Research Society.
Yile Dai No disclosure on file
Holly Martin Holly Martin has nothing to disclose.
Jennifer Gess, PhD Dr. Gess has nothing to disclose.
Yangyu Huang, MD Dr. Huang has nothing to disclose.
Renzo Mancuso, PhD Prof. Mancuso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi.
Tilahun Adera, PhD Prof. Adera has nothing to disclose.
Charlotte Thim Hansen, MD Dr. Hansen has received personal compensation for serving as an employee of Novo Nordisk A/S. Dr. Hansen has stock in Novo Nordisk A/S.
Melissa Sutcliffe, PhD The institution of Dr. Sutcliffe has received research support from Rare Diseases Clinical Research Network.
Guillemette De La Borderie Mrs. De La Borderie has received personal compensation for serving as an employee of UCB Pharma. Mrs. De La Borderie has stock in UCB Pharma.
Marie Aare Bentsen, PhD Dr. Bentsen has received personal compensation for serving as an employee of Novo Nordisk. An immediate family member of Dr. Bentsen has stock in Novo Nordisk.
Chandler Gill, MD Dr. Gill has nothing to disclose.
Aaron E. Izenberg, MD Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aaron Izenberg.
Julian Grosskreutz Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grosskreutz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. The institution of Dr. Grosskreutz has received research support from Boris Canessa Foundation.
Neda Zadeh, MD Dr. Zadeh has nothing to disclose.
Johanne M. Kaplan, PhD Dr. Kaplan has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Kaplan has stock in ProMIS Neurosciences. Dr. Kaplan has received intellectual property interests from a discovery or technology relating to health care.
Maria Vassilaki, MD, PhD The institution of Dr. Vassilaki has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for F. Hoffmann-La Roche Ltd . Dr. Vassilaki has stock in Abbott Laboratories. Dr. Vassilaki has stock in Johnson and Johnson. Dr. Vassilaki has stock in Medtronic. Dr. Vassilaki has stock in Amgen. Dr. Vassilaki has stock in AbbVie. Dr. Vassilaki has stock in Merck. The institution of Dr. Vassilaki has received research support from NIH. The institution of Dr. Vassilaki has received research support from European Union/ St. Anne's University Hospital Brno, Czech Republic. The institution of an immediate family member of Dr. Vassilaki has received research support from Avobis Bio, LLC.
Irina Podkorytova No disclosure on file
Rafael *Use 376887 Joao, MD Prof. João has received research support from FAPESP.
Tonke Van Bragt, Other Mrs. Van Bragt has nothing to disclose.
Leonid Zeitlin, PhD The institution of Dr. Zeitlin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Veranex Solutions.
Sean Selva Sean Selva has nothing to disclose.
Valeria Roldan Ms. Roldan has nothing to disclose.
Cheyenne Batton, Other Miss Batton has received personal compensation for serving as an employee of University of Virginia.
Bushra Javed, MD Dr. Javed has nothing to disclose.
Hemani Ticku, MD Dr. Ticku has nothing to disclose.
Latha Ganti, MD, MS, MBA, FACEP Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer.
David Walk, MD, FAAN No disclosure on file
Brandon Giglio, MD Dr. Giglio has nothing to disclose.
Alfonso Fasano, MD, PhD, FAAN Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sunovion. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. Dr. Fasano has received publishing royalties from a publication relating to health care.
Kelly G. Gwathmey, MD Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Benjamin David Tolchin, MD, FAAN The institution of Dr. Tolchin has received research support from C.G. Swebilius Trust.
Yung-Tian Anjolie Gau, MD, PhD Dr. Gau has nothing to disclose.
David C. Preston, MD, FAAN Dr. Preston has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FBI, US Attorney, Insurance Fraud Investigative Units. Dr. Preston has received publishing royalties from a publication relating to health care.
Pooneh Memar Ardestani, MD, PhD Dr. Memar Ardestani has nothing to disclose.
Gary W. Clauser, MD Dr. Clauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bigoen . The institution of Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech . Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genzyme. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartid.
Michael T. Pulley, MD, PhD Dr. Pulley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion`. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Pulley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pulley has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Multiple law firms.
Rodrigo Zepeda Garcia, MD Dr. Zepeda Garcia has nothing to disclose.
Alvee Saluja, DM Dr. Saluja has nothing to disclose.
Nicole Hersmus Nicole Hersmus has nothing to disclose.
Roger E. Kelley, Jr., MD, FAAN Dr. Kelley has nothing to disclose.
Santiago Clocchiatti-Tuozzo Mr. Clocchiatti-Tuozzo has nothing to disclose.
Hemant Shah, MD Dr. Shah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for gilead.
Jonathan Borg Thomas, MBA Mr. Thomas has nothing to disclose.
Hong Sun, MD, PhD Dr. Sun has received personal compensation for serving as an employee of Janssen.
Nabeel Ahmed Mr. Ahmed has nothing to disclose.
Mustafa Jaffry Mr. Jaffry has nothing to disclose.
Chaim T. Sneiderman Mr. Sneiderman has nothing to disclose.
Carine Karachi, MD,PhD Prof. Karachi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston scientific / Medtronic / Neurotrials.
Kimiaki Utsugisawa, MD,PhD Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Utsugisawa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubisi Tanabe pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion phama. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Japan Blood Products Organization. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Joachim Scholz, MD Dr. Scholz has received personal compensation for serving as an employee of Alexion AstraZeneca Rare Disease. Dr. Scholz has stock in Alexion AstraZeneca Rare Disease. Dr. Scholz has stock in Biogen.
Andrew Stern, MD Dr. Stern has nothing to disclose.
Fernando Cendes, MD, PhD, FAAN Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Yolanda Higueras Yolanda Higueras has nothing to disclose.
Wei Yin Wei Yin has received personal compensation for serving as an employee of Takeda. Wei Yin has stock in Takeda.
Kelly Harper Ms. Harper has nothing to disclose.
Shima *Use 364290 Zargar, MD Dr. Zargar has nothing to disclose.
Michael Shields Perkinton, PhD Dr. Perkinton has stock in AstraZeneca.
Sam Payabvash Sam Payabvash has nothing to disclose.
Karen Hildebrand, Other Miss Hildebrand has nothing to disclose.
Sergiu Groppa Sergiu Groppa has nothing to disclose.
Leticia Franceschet Ribeiro Ms. Ribeiro has nothing to disclose.
Matthew James Rosene, PhD Dr. Rosene has nothing to disclose.
Jin-Hong Shin, MD,PhD Dr. Shin has nothing to disclose.
Brandy Fureman, PhD Dr. Fureman has received personal compensation for serving as an employee of Epilepsy Foundation. The institution of Dr. Fureman has received research support from PCORI/Cincinnati Children's Hospital Medical Center. The institution of Dr. Fureman has received research support from PCORI. The institution of Dr. Fureman has received research support from UCB Biopharma SPRL. The institution of Dr. Fureman has received research support from CDC.
Sarah Lauks, MD Dr. Lauks has nothing to disclose.
Babak Boroojerdi, MD Dr. Boroojerdi has received personal compensation for serving as an employee of UCB Biosciences. Dr. Boroojerdi has stock in UCb Biosciences.
Joel Neves Briard, MD Dr. Neves Briard has received research support from American Academy of Neurology.
Tamar Lengil, PhD Dr. Lengil has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Suresh Kumar Poovathingal, PhD No disclosure on file
Belinda Kaskow, PhD Dr. Kaskow has nothing to disclose.
Erin Furr-Stimming, MD, FAAN Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Michael J. Fox Foundation. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Furr-Stimming has received research support from Huntington's Disease Society of America. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from Sage Therapeutics. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care.
In Collaboration With ADAPT-SC Investigator Study Group No disclosure on file
William *use 123100 Carroll William *use 123100 Carroll has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. William *use 123100 Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. William *use 123100 Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Francis Pike, PhD Dr. Pike has nothing to disclose.
John William Lindsey, MD Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner Life Sciences. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mapi. Dr. Lindsey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Teva. The institution of Dr. Lindsey has received research support from Genentech.
Katheryn Woo, Other Miss Woo has nothing to disclose.
Olivia Iheme, Other Miss Iheme has nothing to disclose.
Poojith Nuthalapati Mr. Nuthalapati has nothing to disclose.
John Vissing, MD Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genethon. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lupin. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from UCB Pharma. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from NOVO Foundation. Prof. Vissing has received research support from Reneo Pharma. Prof. Vissing has received research support from Janssen Pharmaceuticals.
Yuebing Li, MD, PhD, FAAN Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB pharma. Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. The institution of Dr. Li has received research support from Argenx.
Kristofer Davie, PhD Dr. Davie has nothing to disclose.
Timo Wirth Timo Wirth has nothing to disclose.
Serena Simpson Ms. Simpson has nothing to disclose.
Anne-Mette Bjerregaard, PhD Dr. Bjerregaard has received personal compensation for serving as an employee of Novo Nordisk A/S.
Wendemi Sawadogo Dr. Sawadogo has nothing to disclose.
Kristoffer Niss, PhD Dr. Niss has nothing to disclose.
Dylan Makani Mr. Makani has nothing to disclose.
Negar Moheb, MD Dr. Moheb has nothing to disclose.
Hea Ree Park Hea Ree Park has nothing to disclose.
Ann Liebert, PhD Dr. Liebert has received personal compensation for serving as an employee of Symbyx Pty Ltd. Dr. Liebert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SymByx Pty Ltd. Dr. Liebert has stock in SymByx Pty Ltd. The institution of Dr. Liebert has received research support from Gardos family Trust.
Venkata Sriram Chintha, II, MD,MBBS,Other Dr. Chintha has nothing to disclose.
Jeff Guptill, MD, FAAN Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has stock in argenx.
Iain Chessell, PhD Dr. Chessell has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with AstraZeneca.
Sandro Paiva Fernande Alves, PhD Dr. ALVES has nothing to disclose.
Sonny Dhanani, MD The institution of Dr. Dhanani has received research support from Health Canada.
Michael D. Weiss, MD, FAAN Dr. Weiss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB-RA. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Weiss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Soleo. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Elizabeth Crabtree-Hartman, MD Dr. Crabtree-Hartman has nothing to disclose.
Kanika Sharma Ms. Sharma has nothing to disclose.
Mary Jo Pugh, PhD, RN, FAAN The institution of Dr. Pugh has received research support from Department of Defense, Epilepsy Research Program. The institution of Dr. Pugh has received research support from VA Health Services Research and Development Service. The institution of Dr. Pugh has received research support from VA Rehabilitation Research and Development Service. The institution of Dr. Pugh has received research support from Congressionally Directed Research Programs. The institution of Dr. Pugh has received research support from Sanofi.
Alex Keuroghlian, MD Dr. Keuroghlian has received publishing royalties from a publication relating to health care.
Ahmed Moh'd Yassin, MD Dr. Yassin has nothing to disclose.
Petra W. Duda, MD, PhD Dr. Duda has received personal compensation for serving as an employee of UCB. Dr. Duda has stock in UCB.
Octavio Carranza-Renteria, MD Dr. Carranza-Renteria has nothing to disclose.
Hosen Kiat No disclosure on file
Khawla M. Abusamra, MBBS Dr. Abusamra has nothing to disclose.
Tune H. Pers No disclosure on file
Zufe Rizvi, MD Dr. Rizvi has nothing to disclose.
Jeremy Moeller, MD, FAAN Dr. Moeller has received publishing royalties from a publication relating to health care.
Adam De Havenon, MD Dr. De Havenon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has stock in Certus. Dr. De Havenon has stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Neelam Goyal, MD Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. An immediate family member of Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Ericka P. Greene, MD, FAAN Dr. Greene has received personal compensation for serving as an employee of Argenx. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion, Inc. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylx. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Greene has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis . Dr. Greene has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ABPN.
Richard J. Nowak, MD Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. The institution of Dr. Nowak has received research support from Ra Pharma. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Momenta . The institution of Dr. Nowak has received research support from Immunovant . Dr. Nowak has received research support from argenx. Dr. Nowak has received research support from Viela Bio . Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Cyprien Rivier, MD Dr. Rivier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pyxis Partners.
Jeffrey R. Buchhalter, MD, FAAN Dr. Buchhalter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Foundation. Dr. Buchhalter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epilepsy Study Consortium. Dr. Buchhalter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epilog. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shackelford Pharmaceuticals. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex.
Alexander Buslov, MD Dr. Buslov has nothing to disclose.
Susan L. Perlman, MD Dr. Perlman has nothing to disclose.
Zara Abigail Togher, MB BCh BAO Dr. Togher has nothing to disclose.
Rebecca MacRae, MD Dr. MacRae has nothing to disclose.
Alanna McEneny, PhD Dr. McEneny has received personal compensation for serving as an employee of Alexion Pharmaceuticals Inc.. Dr. McEneny has stock in Alexion Pharmaceuticals.
Laura Hwang Miss Hwang has nothing to disclose.
Thomas Gill Thomas Gill has nothing to disclose.
Jeremiah Aakre Jeremiah Aakre has nothing to disclose.
Brendan J. Kelley, MD, FAAN Dr. Kelley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Labcorp. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai.
Sanjeeva Reddy Onteddu, MD, FAAN Dr. Onteddu has nothing to disclose.
Lotte B. Knudsen No disclosure on file
Lance Lim, Other Mr. Lim has nothing to disclose.
Mark Fusunyan, MD Dr. Fusunyan has nothing to disclose.
Denis Korobko, MD,PhD Dr. Korobko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Korobko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Korobko has received personal compensation in the range of $0-$499 for serving as a Consultant for Sanofi. Dr. Korobko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Dr. Korobko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen (Johnson & Johnson company). Dr. Korobko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Korobko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Korobko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen (Johnson & Johnson company).
Sarah Harris Sarah Harris has received personal compensation for serving as an employee of BMS. Sarah Harris has stock in BMS.
Hamza Mohiuddin Ahmed, MBBS Dr. Ahmed has nothing to disclose.
Shitiz K. Sriwastava, MBBS Dr. Sriwastava has nothing to disclose.
Gulin Sunter, PhD No disclosure on file
Stephanie Trend, PhD The institution of Dr. Trend has received research support from MS Australia.
Qiang Johnson Zhang, MD Dr. Zhang has nothing to disclose.
Aparna M. Prabhu, MD Dr. Prabhu has nothing to disclose.
Claire McGee, PT Ms. McGee has nothing to disclose.
P. David Charles, MD, FAAN Dr. Charles has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Charles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Newronika. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota. Dr. Charles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Charles has stock in Arena Therapeutics. The institution of Dr. Charles has received research support from Pharma 2 B. The institution of Dr. Charles has received research support from Intec. The institution of Dr. Charles has received research support from Merz. The institution of Dr. Charles has received research support from Novartis. The institution of Dr. Charles has received research support from Aeon. The institution of Dr. Charles has received research support from Impax.
Mark A. Agostini, MD Dr. Agostini has nothing to disclose.
Georgiana Kuhlmann Georgiana Kuhlmann has received personal compensation for serving as an employee of Amgen. Georgiana Kuhlmann has stock in Amgen.
Eun-Yeon Joo, MD Dr. Joo has nothing to disclose.
Travis J.W. Hassell, MD, PhD No disclosure on file
Wen Liu, Other Mrs. Liu has nothing to disclose.
Masayuki Masuda Masayuki Masuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alexion pharma, Argenix pharma, Aasahi kasei pharma.
Clarissa L. Yasuda, MD, PhD Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Juliane Ashleigh Coutts, Other Ms. Coutts has nothing to disclose.
Renato Mantegazza, MD Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Mantegazza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SERB. The institution of Dr. Mantegazza has received research support from Alpine Immune Sciences, Inc.
Min Yee, Other Dr. Yee has nothing to disclose.
Agessandro Abrahao, Jr., MD Dr. Abrahao has nothing to disclose.
Alan R. Hirsch, MD, FACP Dr. Hirsch has nothing to disclose.
Christopher Adams, MD Dr. Adams has stock in Medtronic.
Deepti Zutshi, MD, FAAN Dr. Zutshi has nothing to disclose.
Tinatin Tkemaladze, MD,PhD Prof. Tkemaladze has nothing to disclose.
Alex Benjamin, MD Dr. Benjamin has nothing to disclose.
Harry Southworth The institution of Harry Southworth has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for BMS.
Farnaz Khalighinejad, MD Dr. Khalighinejad has nothing to disclose.
Maria Luisa Martinez Gines, MD Dr. Martinez Gines has nothing to disclose.
Rebecca T. Hsu, MD Dr. Hsu has nothing to disclose.
Franz Woltering Franz Woltering has received personal compensation for serving as an employee of UCB Biosciences GmbH. Franz Woltering has stock in UCB.
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Motric Bio.
Daniel R. Weinberger, MD No disclosure on file
Elena M. Kleinhenz Ms. Kleinhenz has nothing to disclose.
Lucienne Kirstein, MD Dr. Kirstein has nothing to disclose.
Christopher Reading Dr. Reading has received personal compensation for serving as an employee of Biovie, Inc.. Dr. Reading has received intellectual property interests from a discovery or technology relating to health care.
Rebekah L. S. Summers, PhD, PT Rebekah Summers has received personal compensation for serving as an employee of Medtronic. Rebekah Summers has received research support from National Institute of Health.
Francesco Sacca, MD Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avexis. Dr. Sacca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo therapeutics. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda.
Sarah Ingersoll, RN, PHN The institution of Ms. Ingersoll has received research support from Parkinson's Foundation (PF).
Thapat Wannarong, MD Dr. Wannarong has nothing to disclose.
Ludwig Kappos, MD, FAAN The institution of Dr. Kappos has received research support from Bayer. The institution of Dr. Kappos has received research support from Biogen. The institution of Dr. Kappos has received research support from Genentech. The institution of Dr. Kappos has received research support from Genzyme. The institution of Dr. Kappos has received research support from Janssen. The institution of Dr. Kappos has received research support from Merck Serono. The institution of Dr. Kappos has received research support from Minoryx. The institution of Dr. Kappos has received research support from Novartis. The institution of Dr. Kappos has received research support from Roche. The institution of Dr. Kappos has received research support from Sanofi. The institution of Dr. Kappos has received research support from Santhera. The institution of Dr. Kappos has received research support from Swiss MS Society, Swiss National Research Foundation, European Union, Roche Research Foundation, Innosuisse. The institution of Dr. Kappos has received research support from Shionogi. The institution of Dr. Kappos has received research support from Japan Tobacco. The institution of Dr. Kappos has received research support from Auriga Vision AG. The institution of Dr. Kappos has received research support from EMD Serono. The institution of Dr. Kappos has received research support from Glaxo Smith Kline. The institution of Dr. Kappos has received research support from Wellmera AG. The institution of Dr. Kappos has received research support from Eli Lilly (Suisse) SA. The institution of Dr. Kappos has received research support from Bristol Myers Squibb. The institution of Dr. Kappos has received research support from Celltrion Inc. Dr. Kappos has received intellectual property interests from a discovery or technology relating to health care.
Adrian Rodriguez-Hernandez, MD Dr. Rodriguez-Hernandez has nothing to disclose.
Alexandra Durr, MD The institution of Dr. Durr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Durr has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. The institution of Dr. Durr has received research support from NIH. The institution of Dr. Durr has received research support from BIOGEN. The institution of Dr. Durr has received research support from MINORYX. The institution of Dr. Durr has received research support from TRIPLETS THERAPEUTICS. The institution of Dr. Durr has received research support from Servier. The institution of Dr. Durr has received research support from ANR. The institution of Dr. Durr has received research support from PTC.
Raj Bandaru Mr. Bandaru has received personal compensation for serving as an employee of Alexion Pharmaceuticals.
Brigitte Wildemann, MD Dr. Wildemann has nothing to disclose.
Adrian Charles Newland, MD Prof. Newland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for OakHill Bio. Prof. Newland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Prof. Newland has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Angle PLC. Prof. Newland has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. Prof. Newland has received personal compensation in the range of $10,000-$49,999 for serving as a Chair, Clinical Board with BMI Healthcare.
Kenneth Hayashida Kenneth Hayashida has nothing to disclose.
Mark Sands, PhD Prof. Sands has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for M6P Therapeutics. Prof. Sands has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amicus. Prof. Sands has stock in JAYA Biosciences. The institution of Prof. Sands has received research support from JAYA Biosciences. Prof. Sands has received intellectual property interests from a discovery or technology relating to health care.
Abhishek Aggarwal, MD, MBBS No disclosure on file
Goutam Gangopadhyay Goutam Gangopadhyay has nothing to disclose.
Lisa Tonder Lisa Tonder has received personal compensation for serving as an employee of Medtronic. An immediate family member of Lisa Tonder has received personal compensation for serving as an employee of Medtronic.
Jordan Broman-Fulks, MD No disclosure on file
Rohit Das, MD, FAAN Dr. Das has received personal compensation for serving as an employee of Concentra. Dr. Das has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for janicek. The institution of an immediate family member of Dr. Das has received research support from NIH.
Yuzhou Guan No disclosure on file
Minh Cong Pham Mr. Pham has nothing to disclose.
Majd Ahmad Yahya Mr. Yahya has nothing to disclose.
Yaseen Yacoob, MD Dr. Yacoob has nothing to disclose.
Helen Bronte-Stewart, MD, MSE Dr. Bronte-Stewart has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic Inc.
Ruchira M. Jha, MD Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. An immediate family member of Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal fees. The institution of Dr. Jha has received research support from NIH/NINDS, Chuck Noll Foundation, University of Pittsburgh, Barrow Neurological Foundation.
Serena Liao, PhD Dr. Liao has received personal compensation for serving as an employee of Alexion.
Armin Maghsoudlou, MD Dr. Maghsoudlou has nothing to disclose.
Animesh Das, MD Dr. Das has nothing to disclose.
Heinz Wiendl, MD, FAAN Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NexGen. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Worldwide Clinical Trials. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Alexion. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Maria Andrea Donahue, MD Dr. Donahue has nothing to disclose.
Sindhu Ramchandren, MD Dr. Ramchandren has received personal compensation for serving as an employee of Janssen Pharmaceutical Companies of Johnson & Johnson. Dr. Ramchandren has a non-compensated relationship as a Scientific Advisory Board Member with CMT Research Foundation (CMTRF) that is relevant to AAN interests or activities.
Geoffrey Kenneth Herkes, PhD, FRACP, MBBS The institution of Dr. Herkes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Epiminder. Dr. Herkes has received personal compensation in the range of $5,000-$9,999 for serving as a Chair of Advisory Committee of Medicines with Therapeutic Goods Admin.
James F. Howard, Jr., MD, FAAN Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for arenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ra Pharma (now UCB Biosciences). Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi US. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Zai Laboratories. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medscape CME. Dr. Howard has stock in General Electric dividends. Dr. Howard has stock in Johnson & Johnson dividends. Dr. Howard has stock in Pfizer dividends. An immediate family member of Dr. Howard has stock in GlaxoSmithKline dividends. An immediate family member of Dr. Howard has stock in GE Healthcare dividends. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Duke University (DCRI). The institution of Dr. Howard has received research support from Cartestian Therapeutics. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities.
Henry Millard Lee, III, MD Dr. Lee has nothing to disclose.
Joao Vitor Mahler Ferreira Oliveira Mr. Mahler Ferreira Oliveira has nothing to disclose.
Jenna Casey Jenna Casey has received personal compensation for serving as an employee of argenx.
Kevin N. Sheth, MD, FAAN Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Stephanie Gonzalez Mejias, MD Dr. Gonzalez Mejias has nothing to disclose.
Juan Pablo Cuello Juan Pablo Cuello has nothing to disclose.
Maja Kostic, MD Dr. Kostic has nothing to disclose.
Elif Pinar Coskun, MD Dr. Coskun has nothing to disclose.
Andreas Meisel, MD Prof. Meisel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Meisel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argnx. Prof. Meisel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Prof. Meisel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Prof. Meisel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argnx. Prof. Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Prof. Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argnx. Prof. Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. Prof. Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hormosan. The institution of Prof. Meisel has received research support from Octapharma. The institution of Prof. Meisel has received research support from Alexion. Prof. Meisel has received personal compensation in the range of $500-$4,999 for serving as a Auditor with Deutsche Myasthenie Gesellschaft / Bundesinstitut für Qualität und Patientensicherheit.
Shazia Mirza, MBBS Dr. Mirza has nothing to disclose.
Myrte Merkestein, PhD Dr. Merkestein has received personal compensation for serving as an employee of Novo Nordisk A/S.
Jane Yang, MD Dr. Yang has received personal compensation for serving as an employee of Labcorp.
Brian Sacks, DO Mr. Sacks has nothing to disclose.
Isabelle Pouliquen Mrs. Pouliquen has received personal compensation for serving as an employee of AstraZeneca. Mrs. Pouliquen has received personal compensation for serving as an employee of GSK. Mrs. Pouliquen has stock in GSK. Mrs. Pouliquen has stock in AstraZeneca.
Komal Kumari, MBBS Dr. Kumari has nothing to disclose.
Aditya Bharatha Aditya Bharatha has nothing to disclose.
Marisara Dieppa, MD Dr. Dieppa has nothing to disclose.
Stefan Bittner Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Biogen Idec. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Merck Healthcare. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Novartis. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Roche. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Sanofi. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Bristol-Meyer-Squibbs. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Teva.
Courtney Seigel Miss Seigel has nothing to disclose.
David Denney David Denney has nothing to disclose.
Violaine K. Harris, PhD No disclosure on file
Haydee Goicochea Briceño haydee goicochea briceño has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. haydee goicochea briceño has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche. haydee goicochea briceño has received personal compensation in the range of $0-$499 for serving as a Consultant for Almirrall. haydee goicochea briceño has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. haydee goicochea briceño has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. haydee goicochea briceño has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva. haydee goicochea briceño has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merk. haydee goicochea briceño has received research support from IOMSN.
Wilgee Eila *use 378631 Abbot, MD Ms. Abbot has nothing to disclose.
Yu-Ting Chen, MD Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam.
Mya C. Schiess, MD Dr. Schiess has nothing to disclose.
Eonjung Kim, MD Dr. Kim has nothing to disclose.
Partha Nandy No disclosure on file
Angela Lynn Meunier, Other Miss Meunier has nothing to disclose.
Maithreyi Chappidi, MD Dr. Chappidi has nothing to disclose.
Vanessa Sui, MD Dr. Sui has nothing to disclose.
Thiago Pinheiro, MD Dr. Pinheiro has nothing to disclose.
Shane Perrine, PhD The institution of Dr. Perrine has received research support from NIH.
Kadriye Agan Kadriye Agan has nothing to disclose.
Rene Kerstens, Other Mr. Kerstens has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Argenx.
Henry J. Kaminski, MD, FAAN The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Kaminski has stock in ARC Biotechnology. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
Scott Grossman, MD Dr. Grossman has nothing to disclose.
Nicollette Purcell No disclosure on file
Aline Herlopian, MD Dr. Herlopian has nothing to disclose.
Susan Walters Susan Walters has nothing to disclose.
Tobias Ruck, MD Dr. Ruck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme.
Anam Khalid Shaikh Miss Shaikh has nothing to disclose.
Hubert H. Fernandez, MD, FAAN Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Fernandez has received research support from Biogen. The institution of Dr. Fernandez has received research support from Michael J Fox Founda. The institution of Dr. Fernandez has received research support from Roche. The institution of Dr. Fernandez has received research support from Parkinson Foundation. The institution of Dr. Fernandez has received research support from UCB. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Kelly Y. Chun, PhD Dr. Chun has nothing to disclose.
Tandees Najimi Ms. Najimi has received research support from National Institutes of Health's Intramural Research Program.
Elizabeth Woods Fletman, DO Dr. Fletman has nothing to disclose.
Jesse Thon, MD An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Focus group participant with Alexion.
Joseph Nahas, MD Dr. Nahas has nothing to disclose.
Christopher George Favilla, MD The institution of Dr. Favilla has received research support from National Institutes of Health. The institution of Dr. Favilla has received research support from American Heart Association. The institution of Dr. Favilla has received research support from OpenWater, Inc..
Ria Trivedi Miss Trivedi has nothing to disclose.
Sergio Baranzini Sergio Baranzini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono. Sergio Baranzini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Sergio Baranzini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Aventis. Sergio Baranzini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nexilico. Sergio Baranzini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono . Sergio Baranzini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD SErono. Sergio Baranzini has stock in MATE Bioservices. The institution of Sergio Baranzini has received research support from Valhalla Charitable Fund. The institution of Sergio Baranzini has received research support from Genentech Inc. The institution of Sergio Baranzini has received research support from Salah Foundation.
Alameen Ahmed Alsabbah, MD Mr. Alsabbah has nothing to disclose.
Jocelyn Leu, PhD,Other Dr. Leu has received personal compensation for serving as an employee of Janssen Research & Development. Dr. Leu has stock in Janssen Research & Development.
Beibei Zhao Beibei Zhao has received intellectual property interests from a discovery or technology relating to health care.
Hongying Chen, MB BCh BAO Dr. Chen has nothing to disclose.
Hester Visser Hester Visser has received personal compensation for serving as an employee of Amneal Pharmaceuticals LLC. Hester Visser has received stock or an ownership interest from Amneal Pharmaceuticals LLC.
Ludo Van Den Bosch The institution of Ludo Van Den Bosch has received research support from FWO-Vlaanderen. The institution of Ludo Van Den Bosch has received research support from Muscular Dystrophy Association (MDA). The institution of Ludo Van Den Bosch has received research support from American ALS Association (ALSA). The institution of Ludo Van Den Bosch has received research support from Thierry Latran Foundation. The institution of Ludo Van Den Bosch has received research support from Target ALS. The institution of Ludo Van Den Bosch has received research support from ABMM.
Felix Lüssi, MD Dr. Lüssi has nothing to disclose.
Dylan Rausch, PhD Dr. Rausch has nothing to disclose.
Sven G. Meuth Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Shailee Samir Shah, MD Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Shah has received publishing royalties from a publication relating to health care.
Marek Smilowski, MD,PhD Dr. Smilowski has nothing to disclose.
Tabitha Karatz Ms. Karatz has nothing to disclose.
Nagaraja Sarangmat, Other Dr. Sarangmat has nothing to disclose.
Jens Kuhle, MD Dr. Kuhle has nothing to disclose.
Angelina H. Maniaol, MD Dr. Maniaol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Maniaol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Maniaol has received research support from ALS patient organization Alltid litt sterkere.
Emily Tharp, MD Dr. Tharp has nothing to disclose.
Jan Lünemann, MD Dr. Lünemann has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ArgenX. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma GmbH. The institution of Dr. Lünemann has received research support from German Research Foundation. The institution of Dr. Lünemann has received research support from French National Research Agency (ANR). The institution of Dr. Lünemann has received research support from National Multiple Sclerosis Society (NMSS). The institution of Dr. Lünemann has received research support from National Institute of Health.
Camila Pupe, MD Dr. Pupe has nothing to disclose.
Anju Parthan Anju Parthan has received personal compensation for serving as an employee of Alexion. Anju Parthan has received personal compensation for serving as an employee of Alkermes. Anju Parthan has received stock or an ownership interest from Alexion.
Yashmi Shirish Sevak, Other Miss Sevak has nothing to disclose.
Hiroyuki Murai, MD Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharmaceutical. The institution of Dr. Murai has received research support from Japan Blood Products Organization.
Arnav Mahajan Mr. Mahajan has nothing to disclose.
Jacob Hawkins No disclosure on file
Ashley Bailey, MD Dr. Bailey has nothing to disclose.
Zsuzsanna Bata-Csorgo, MD,PhD Prof. Bata-Csorgo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme Hungary. The institution of Prof. Bata-Csorgo has received research support from NKFI Hungary. Prof. Bata-Csorgo has received publishing royalties from a publication relating to health care.
Mateus Nogueira Mateus Nogueira has nothing to disclose.
Stanley Taylor, Other Mr. Taylor has nothing to disclose.
Rachel Kenney Rachel Kenney has nothing to disclose.
Bernhard Greve, MD Dr. Greve has received personal compensation for serving as an employee of UCB Biosciences. Dr. Greve has stock in UCB Biosciences.
Vanessa K. Hinson, MD, PhD, FAAN The institution of Dr. Hinson has received research support from Biogen. The institution of Dr. Hinson has received research support from Scion Neurostim. The institution of Dr. Hinson has received research support from PPD Development/Takeda Development. The institution of Dr. Hinson has received research support from Parexel Biopharma. The institution of Dr. Hinson has received research support from Impax Laboratories.
Haneen Faisal Al Refa'i Ms. Al Refa'i has nothing to disclose.
Cankatika Choudhury, DM Dr. Choudhury has nothing to disclose.
Jiayu Shi No disclosure on file
Jayne R. Wilkinson, MD, MSCE Dr. Wilkinson has nothing to disclose.
Alanna Marie Ritchie Mrs. Ritchie has nothing to disclose.
Eva Eilers, PhD Dr. Eilers has nothing to disclose.
Salim Chahin, MD Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen. The institution of Dr. Chahin has received research support from National MS Society. The institution of Dr. Chahin has received research support from BMS.
James M. Winkley, MD Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biogen. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Sanofi. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Novartis. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Serrono. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Teva. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Biogen. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Sanofi. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Serrono. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Novartis. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Roche. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Winkley has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for lilly. Dr. Winkley has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. The institution of Dr. Winkley has received research support from Noveratis. The institution of Dr. Winkley has received research support from Merck. The institution of Dr. Winkley has received research support from Sanofi. The institution of Dr. Winkley has received research support from Biogen. The institution of Dr. Winkley has received research support from Alexion.
Krista Ocier, PhD Dr. Ocier has nothing to disclose.
Christopher Melinosky, MD Dr. Melinosky has nothing to disclose.
Khalid El-Salim No disclosure on file
Suradech Suthiphosuwan, MD Dr. Suthiphosuwan has nothing to disclose.
Ricardo Brioschi No disclosure on file
Khurram Bashir, MD The institution of Dr. Bashir has received research support from NIH. The institution of Dr. Bashir has received research support from PICORI. The institution of Dr. Bashir has received research support from Sanofi. Dr. Bashir has received research support from GWSP. The institution of Dr. Bashir has received research support from Roche. The institution of Dr. Bashir has received research support from Novartis. The institution of Dr. Bashir has received research support from Hoffmann-La Roche.
Keshav Jayeshbhai Shah, MD Mr. Shah has nothing to disclose.
Catherine M. Cowan, PhD Dr. Cowan has nothing to disclose.
Joseph Djan Mr. Djan has received personal compensation for serving as an employee of BioVie Inc..
Juan Jose Pérez Ruixo, PhD Dr. Pérez Ruixo has received personal compensation for serving as an employee of Janssen R&D. Dr. Pérez Ruixo has stock in Johnson & Johnson. Dr. Pérez Ruixo has stock in Amgen.
Dana Allison Ms. Allison has nothing to disclose.
Elena Ratti, MD Dr. Ratti has received personal compensation for serving as an employee of Takeda. Dr. Ratti has received personal compensation for serving as an employee of Biogen. Dr. Ratti has stock in Takeda. Dr. Ratti has stock in Biogen.
Mohammad Shahnawaz, PhD The institution of Dr. Shahnawaz has received research support from American Parkinson Disease Association. The institution of Dr. Shahnawaz has received research support from NIH. The institution of Dr. Shahnawaz has received research support from Texas Alzheimer's Research & Care Consortium . Dr. Shahnawaz has received intellectual property interests from a discovery or technology relating to health care.
Daniel Basoff, PharmD, RPh Dr. Basoff has received personal compensation for serving as an employee of Alexion Pharmaceuticals.
Masahisa Katsuno, MD,PhD Prof. Katsuno has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Esai. Prof. Katsuno has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono Pharmaceutical. Prof. Katsuno has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda Pharmaceutical. Prof. Katsuno has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen Japan. The institution of Prof. Katsuno has received research support from Alexion. The institution of Prof. Katsuno has received research support from Alnylam. The institution of Prof. Katsuno has received research support from Zenyaku Kogyo. The institution of Prof. Katsuno has received research support from Mitsubishi-Tanabe Pharmaceutical. The institution of Prof. Katsuno has received research support from JB. The institution of Prof. Katsuno has received research support from Esai. The institution of Prof. Katsuno has received research support from Takeda Pharmaceutical. The institution of Prof. Katsuno has received research support from CSL Behling. The institution of Prof. Katsuno has received research support from Otsuka Pharmaceutical. The institution of Prof. Katsuno has received research support from Daiichi Sankyo. The institution of Prof. Katsuno has received research support from Sumitomo Dainippon Pharma.
Gregory Owens, PhD No disclosure on file
Channa Adithya Hewamadduma, PhD, MBBS, FRCP, FRC Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARENX. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. The institution of Dr. Hewamadduma has received research support from Neurocare . The institution of Dr. Hewamadduma has received research support from Sheffield Charitable Trust. Dr. Hewamadduma has received personal compensation in the range of $5,000-$9,999 for serving as a Adult Expert with National Health Service England (NHSE).
Brian Pugsley Brian Pugsley has nothing to disclose.
Kevin O'Dell No disclosure on file
Maryam Hosseini, MD Dr. Hosseini has nothing to disclose.
Ventaka Bendi, MBBS Dr. Bendi has nothing to disclose.
Zurisadai Gonzalez Castillo, MD Dr. Gonzalez Castillo has nothing to disclose.
Glen Frick, MD,PhD Dr. Frick has received personal compensation for serving as an employee of AstraZeneca/Alexion Rare Disease. Dr. Frick has stock in AstraZeneca/Alexion Rare Disease.
Joan O'Keefe Joan O'Keefe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avexis, Inc.
Robert J. Kubiak Dr. Kubiak has received personal compensation for serving as an employee of AstraZeneca. Dr. Kubiak has stock in AstraZeneca.
Dean Fergusson Dean Fergusson has nothing to disclose.
Jose Manuel Garcia Dominguez Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall.
Fnu Arti, MD,MBBS Dr. Arti has nothing to disclose.
Sam Leo, PharmD Dr. Leo has received personal compensation for serving as an employee of Teva Pharmaceutical Industries.
Harry William Sutherland, MD Dr. Sutherland has received personal compensation in the range of $0-$499 for serving as a Consultant for McGraw-Hill.
Oscar Alberto Vargas Cifuentes Mr. Vargas Cifuentes has nothing to disclose.
Patrick M. Kochanek, MD, MCCM Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Johns Hopkins Health System. The institution of Patrick M. Kochanek, MD, MCCM has received research support from Chuck Noll Foundation. The institution of Patrick M. Kochanek, MD, MCCM has received research support from NIH. Patrick M. Kochanek, MD, MCCM has received publishing royalties from a publication relating to health care.
Richard D'Souza No disclosure on file
Mette Ludwig, PhD Dr. Ludwig has nothing to disclose.
Sarah R. Durica, MD An immediate family member of Dr. Durica has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Federal Aviation Administration.
Maggie Moran, MD Dr. Moran has nothing to disclose.
Ying Tan, MD Dr. Tan has nothing to disclose.
Frauke Zipp, MD Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Zipp has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. The institution of Dr. Zipp has received research support from BMBF. The institution of Dr. Zipp has received research support from DFG. The institution of Dr. Zipp has received research support from PMSA. The institution of Dr. Zipp has received research support from Sanofi Genzyme. The institution of Dr. Zipp has received research support from UCB. The institution of Dr. Zipp has received research support from Eisai. The institution of Dr. Zipp has received research support from SK Life Science. The institution of Dr. Zipp has received research support from Abbott. The institution of Dr. Zipp has received research support from Actelion. The institution of Dr. Zipp has received research support from Bayer. The institution of Dr. Zipp has received research support from Servier. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Novartis. Dr. Zipp has received personal compensation in the range of $0-$499 for serving as a Reviewer with Universite de Geneve. Dr. Zipp has received personal compensation in the range of $5,000-$9,999 for serving as a Reviewer with Oppenheim Förderpreis für Multiple Sklerose. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with EKFS. Dr. Zipp has a non-compensated relationship as a Associate Editor with Brain that is relevant to AAN interests or activities. Dr. Zipp has a non-compensated relationship as a Advisor with Science Translational Medicine that is relevant to AAN interests or activities.
Michael Francis Maimon Cronin The institution of Mr. Cronin has received research support from American Heart Association.
Dorte Holst No disclosure on file
Alexander Sherman The institution of Mr. Sherman has received research support from The ALS Association. The institution of Mr. Sherman has received research support from NIH. The institution of Mr. Sherman has received research support from FDA. Mr. Sherman has a non-compensated relationship as a Member, Board of Directors with ALD Connect that is relevant to AAN interests or activities.
Joseph Michael Palumbo, MD Dr. Palumbo has received personal compensation for serving as an employee of BioVie. An immediate family member of Dr. Palumbo has received personal compensation for serving as an employee of Merck Research Laboratories. Dr. Palumbo has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BioVie. Dr. Palumbo has stock in BioVie. An immediate family member of Dr. Palumbo has stock in Merck Research Laboratories. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care.
Hamada Hamid Altalib, DO The institution of Dr. Altalib has received research support from UCB. The institution of Dr. Altalib has received research support from Eisai. The institution of Dr. Altalib has received research support from Sunovian. The institution of Dr. Altalib has received research support from DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS.
Maria Eveslage Maria Eveslage has nothing to disclose.
Thomas C. Hammond, MD, FAAN Dr. Hammond has nothing to disclose.
Yasushi Suzuki, MD, PhD Yasushi Suzuki, MD, PhD has nothing to disclose.
Sarah Brighton, Other Miss Brighton has nothing to disclose.
Lourdes Fatima Yllana Pérez Mrs. Yllana Pérez has nothing to disclose.
Andrew Morrison, MD Mr. Morrison has nothing to disclose.
Jennifer Hannah Newman, MD Dr. Newman has nothing to disclose.
Luis Alberto Sierra, Jr. Mr. Sierra has nothing to disclose.
Muhammad Makkieh, DO Dr. Makkieh has nothing to disclose.
Emma McFadden, PhD Dr. McFadden has nothing to disclose.
Eunice Jiyoung Lee, MD Dr. Lee has nothing to disclose.
Lisa Lohmann Lisa Lohmann has nothing to disclose.
Alex Berger, BS Mr. Berger has nothing to disclose.
Bruno Benitez Bruno Benitez has nothing to disclose.
Bhaswar Bhattacharya, Jr. Dr. Bhattacharya has nothing to disclose.
Kranthi Kiran Mandava Mr. Mandava has nothing to disclose.
Clementina Julia Ullman Miss Ullman has nothing to disclose.
Kristoffer L. Egerod No disclosure on file
Shayan Abdollah Zadegan, MD Dr. Zadegan has nothing to disclose.
Zujian Xiong, MD,PhD Dr. Xiong has nothing to disclose.
Neil R. Cashman, MD Dr. Cashman has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Cashman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Dr. Cashman has stock in ProMIS Neurosciences. The institution of Dr. Cashman has received research support from ProMIS Neurosciences. Dr. Cashman has received intellectual property interests from a discovery or technology relating to health care. Dr. Cashman has a non-compensated relationship as a BoD memeber with ALS Society of BC that is relevant to AAN interests or activities.
Pradeepthi Badugu, MBBS Dr. Badugu has nothing to disclose.
Nouf Salem Al-Faidi, MD Dr. Al-Faidi has nothing to disclose.
Catharina Korsukewitz, MD Dr. Korsukewitz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Korsukewitz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Korsukewitz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Will Keizo Tanigaki, MD Mr. Tanigaki has nothing to disclose.
Ming Jiang, MD Mrs. Jiang has received personal compensation for serving as an employee of argenx BV.
Matteo Locatelli, BS Mr. Locatelli has nothing to disclose.
Jori Fleisher, MD, MSCE, FAAN The institution of Dr. Fleisher has received research support from Parkinson's Foundation. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NIA/Emory Roybal Center for Dementia Caregiving Mastery. Dr. Fleisher has received publishing royalties from a publication relating to health care. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Parkinson's Foundation. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lewy Body Dementia Association. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Davis Phinney Foundation. Dr. Fleisher has a non-compensated relationship as a Editorial Board Member with AAN Brain & Life Magazine that is relevant to AAN interests or activities.
Ahmer Asif, MD Dr. Asif has nothing to disclose.
Karen A. Truitt, DO Dr. Truitt has stock in NVTA. Dr. Truitt has stock in QTRX. Dr. Truitt has stock in EXAS. Dr. Truitt has stock in ALC. Dr. Truitt has stock in ACAD. Dr. Truitt has stock in ABBV. Dr. Truitt has stock in NVS. Dr. Truitt has stock in VRTX. Dr. Truitt has stock in MRK. Dr. Truitt has stock in ATRI. Dr. Truitt has stock in HZNP. Dr. Truitt has stock in ZM.
Sathvik S Shastry, MD Dr. Shastry has nothing to disclose.
Jack Turban No disclosure on file
Rory Abrams, MD Dr. Abrams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Averitas Pharmaceutical.
Maryam Gayfieva, MD Dr. Gayfieva has nothing to disclose.
James K. Sheffield, MD Dr. Sheffield has received personal compensation for serving as an employee of BMS.
Ebrima Gibbs, Bsc,BMLSc,MSc Dr. Gibbs has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Promis Neuroscinces.
Ahmad Al-Awwad, MD Dr. Al-Awwad has nothing to disclose.
Jan Noukens, Other Mr. Noukens has nothing to disclose.
Shari Meyerson, MD Dr. Meyerson has nothing to disclose.
Taylor Abel, MD Dr. Abel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical.
Maria Daniela Olaya Galindo, MD Mrs. Olaya Galindo has nothing to disclose.
Audrey Serena Wack The institution of an immediate family member of Miss Wack has received research support from Canon Medical Systems USA, Inc.
Leonardo B. Almeida, MD No disclosure on file
Kathleen Beasley, PharmD Dr. Beasley has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Dr. Beasley has received stock or an ownership interest from Alexion, AstraZeneca Rare Disease.
Denise K. Sebasigari, MD Dr. Sebasigari has nothing to disclose.
Lucy Elizabeth Gee, PhD Dr. Gee has nothing to disclose.
Rohini D. Samudralwar, MD Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Nicole Sukkarieh Ms. Sukkarieh has nothing to disclose.
Vera Bril, MD Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Rosa Willock Ms. Willock has received personal compensation for serving as an employee of HCD Economics.
Hisham Gibriel Bakhiet Elkhider, MD Dr. Elkhider has nothing to disclose.
Hans D. Katzberg, MD, FAAN An immediate family member of Dr. Katzberg has received personal compensation for serving as an employee of Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Katzberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Ghazala Perven, MD Dr. Perven has nothing to disclose.
Natalia Pessoa Rocha Natalia Pessoa Rocha has nothing to disclose.
Neera Chaudhry Prof. CHAUDHRY has nothing to disclose.
Craig McLachlan No disclosure on file
Thirumalaivasan Dhasakeerthi, MBBS Dr. Dhasakeerthi has nothing to disclose.
Jessica Sanders, MD The institution of Dr. Sanders has received research support from Autism Intervention Research Network on Physical Health. The institution of Dr. Sanders has received research support from Accreditation Council for Graduate Medical Education.
Anusorn Thanataveerat, Other Dr. Thanataveerat has received personal compensation for serving as an employee of Genesis Research. Dr. Thanataveerat has received personal compensation for serving as an employee of Aetion.
Denis Babici, MD Dr. Babici has nothing to disclose.
Brian Bicknell, PhD Dr. Bicknell has received personal compensation for serving as an employee of SymByx Pty Ltd. Dr. Bicknell has stock in SymByx. Pty Ltd.
Marilyn Victoria Ann Dias Miss Dias has nothing to disclose.
Christopher Bentley Traner, MD Dr. Traner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Traner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Resident Matching Program .
Juan De-León Luis juan de-leon ruiz has nothing to disclose.
Sara Abdullah Alnajjar, Jr., MD Dr. Alnajjar has nothing to disclose.
Svetlana Faktorovich, MD Dr. Faktorovich has a non-compensated relationship as a Board of Directors with Brother's Brother Foundation that is relevant to AAN interests or activities.
Xubiao Peng No disclosure on file
Dennis William Simon, MD Dr. Simon has nothing to disclose.
Kris Mendenhall Kris Mendenhall has nothing to disclose.
Juergen Haas Juergen Haas has nothing to disclose.
Seneca Oxendine Ms. Oxendine has nothing to disclose.
Mark Forrest Gordon, MD, FAAN Dr. Gordon has received personal compensation for serving as an employee of Teva. Dr. Gordon has stock in Teva.
Divya M. Radhakrishnan, MD, DM Neurology Dr. Radhakrishnan has received research support from Indian Council of Medical Research, New Delhi, India. Dr. Radhakrishnan has received research support from World Federation of Neurology .
Paul Banerjee No disclosure on file
Christian LoBue, PhD The institution of Dr. LoBue has received research support from NIA. The institution of Dr. LoBue has received research support from Alzheimer's Association. The institution of Dr. LoBue has received research support from Department of Defense. The institution of Dr. LoBue has received research support from AWARE Organization.
Mark Fiers No disclosure on file
Yash Nene, MBBS Dr. Nene has nothing to disclose.
Charlene Jennifer Ong, MD Dr. Ong has nothing to disclose.
Nicholas Schwab The institution of Nicholas Schwab has received research support from Biogen. The institution of Nicholas Schwab has received research support from Roche.
Eric Molho, MD, FAAN Dr. Molho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Molho has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CNS Ratings. Dr. Molho has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences.
Praveen Kumar Amancha, PhD Dr. Amancha has nothing to disclose.
GM Fahad Bin Mostafa Mr. Mostafa has nothing to disclose.
Elena Moro, MD, FAAN Dr. Moro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic, Abbott, Kyowa. Dr. Moro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Moro has received research support from Abbott. The institution of Dr. Moro has received research support from IPSEN.
Laura Fumagalli No disclosure on file
Mohsen Ahmed Mr. Ahmed has nothing to disclose.
Padmaja Sudhakar, MD Dr. Sudhakar has nothing to disclose.
Marie-Francoise Doursout Marie-Francoise Doursout has nothing to disclose.
Aliese Sarkissian, MD Dr. Sarkissian has nothing to disclose.
David Cherney, MD,PhD Prof. Cherney has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Boehringer Ingelheim-Lilly, Merck, AstraZeneca, Sanofi, Mitsubishi-Tanabe, Abbvie, Janssen, Bayer, Prometic, BMS, Maze, Gilead, CSL-Behring, Otsuka, Novartis, Youngene and Novo-Nordisk (amounts vary per company and year). The institution of Prof. Cherney has received research support from Boehringer Ingelheim-Lilly, Merck, Janssen, Sanofi, AstraZeneca, CSL-Behring and Novo-Nordisk.
Marion Boehnlein Marion Boehnlein has received personal compensation for serving as an employee of UCB Pharma. Marion Boehnlein has stock in UCB Pharma.
Ramsha Ali Bhutta, MD Dr. Bhutta has nothing to disclose.
Tyler Lee Borko, BA, EMT-IV Mr. Borko has nothing to disclose.
Kaitlyn Lillemoe, MD Dr. Lillemoe has nothing to disclose.
Julia Sophie Frueh, MD Dr. Frueh has received research support from ACGME Back to Bedside.
Anjali Banerjee No disclosure on file
Clarence Ahlem Mr. Ahlem has received personal compensation for serving as an employee of Biovie, Inc.. Mr. Ahlem has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Biovie, Inc.. Mr. Ahlem has received intellectual property interests from a discovery or technology relating to health care.
Karthinathan Thangavelu Karthinathan Thangavelu has received personal compensation for serving as an employee of Sanofi Genzyme. Karthinathan Thangavelu has received personal compensation for serving as an employee of EMD Serono .
Anne-Gaelle Dosne Dr. Dosne has received personal compensation for serving as an employee of Johnson&Johnson. Dr. Dosne has stock in Johnson&Johnson.
Joshua Chodosh, MD The institution of Dr. Chodosh has received research support from NIH-NIA. The institution of Dr. Chodosh has received research support from NIH-NIMHD. The institution of Dr. Chodosh has received research support from NIH-NINR. The institution of Dr. Chodosh has received research support from SCAN Health Plan. The institution of Dr. Chodosh has received research support from New York State Department of Health.
Ofir Harari, PhD The institution of Dr. Harari has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cytel Inc..
Gerald Smith, Other The institution of Mr. Smith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cytel Inc..
Malissa Pynes, MD Dr. Pynes has nothing to disclose.
Hortense Hurmic, Other Mrs. HURMIC has nothing to disclose.
Christa Suzanne Cooper, PA No disclosure on file
Steven S. Plotkin Steven S. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ProMIS Neurosciences. Steven S. Plotkin has stock in ProMIS Neurosciences. The institution of Steven S. Plotkin has received research support from Canadian Institutes of Health Research. The institution of Steven S. Plotkin has received research support from Digital Technology Supercluster. Steven S. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Shreya Reddy P, MBBS Dr. P has nothing to disclose.
Brooke L. Valdez, Other Ms. Valdez has a non-compensated relationship as a Valdez with The Rocky Mountain MS Center non-profit partner that is relevant to AAN interests or activities.
Christopher Hemond, MD Dr. Hemond has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for VIVIO Health. Dr. Hemond has stock in VIVIO Health. The institution of Dr. Hemond has received research support from Consorium of Multiple Sclerosis Centers. The institution of Dr. Hemond has received research support from National Multiple Sclerosis Society. The institution of Dr. Hemond has received research support from National Center for Advancing Translational Sciences, National Institutes of Health. The institution of Dr. Hemond has received research support from University of Massachusetts Memorial Medical Center. The institution of Dr. Hemond has received research support from National Institute Of Neurological Disorders And Stroke of the National Institutes of Health. Dr. Hemond has received personal compensation in the range of $0-$499 for serving as a Member of Data Safety and Monitoring Board with National Institute Of Neurological Disorders And Stroke of the National Institutes of Health.
Shanna Patterson, MD Dr. Patterson has nothing to disclose.
Gabriel Ferri Baltazar Dr. Baltazar has nothing to disclose.
Tuan Hoang Vu, MD Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BPL. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MedScape. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from Mitsubishi Tanaka. The institution of Dr. Vu has received research support from Mass Gen Hospital/Healy Platform Study. The institution of Dr. Vu has received research support from Amylyx Pharma. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Alector. The institution of Dr. Vu has received research support from Annexon. The institution of Dr. Vu has received research support from Apellis. The institution of Dr. Vu has received research support from Cytokinetics. The institution of Dr. Vu has received research support from Sanofi. The institution of Dr. Vu has received research support from Horizon. The institution of Dr. Vu has received research support from Woolsey Pharma. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Momenta.
Michael Chasse Michael Chasse has nothing to disclose.
Evan El-Halawani Mr. El-Halawani has nothing to disclose.
Meredith Schultz, MD Dr. Schultz has received personal compensation for serving as an employee of AskBio.
Reza Mohammed Ali Mr. Mohammed Ali has nothing to disclose.
Shwetha Menon, MD Ms. Menon has nothing to disclose.
Aleksandra Maleska Maceski Aleksandra Maleska Maceski has nothing to disclose.
Clara Baselga-Garriga, Other Ms. Baselga-Garriga has nothing to disclose.
Anna Shah, MD The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Shah has received personal compensation in the range of $5,000-$9,999 for serving as a Educational Speaker with Rocky Mountain MS Center.
Marina Koutsodontis Alvim Dr. Alvim has nothing to disclose.
Iffat Jabeen, MD Dr. Jabeen has nothing to disclose.
Vinzenz Fleischer, MD Dr. Fleischer has nothing to disclose.
Jeff Edwards, PhD Dr. Edwards has nothing to disclose.
Christina Istrate, MD Dr. Istrate has nothing to disclose.
Rasha Aguzzi, Other Mrs. Aguzzi has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease.
Yan Xu No disclosure on file
Mohammad Dibs, MD Dr. Dibs has nothing to disclose.
Eldon Loh, MD Dr. Loh has stock in Dara3D.
Courtney Curran, MD Dr. Curran has nothing to disclose.
Kevin Dalgaard, PhD Dr. Dalgaard has received personal compensation for serving as an employee of Novo Nordisk.
Nathan P. Young, DO Dr. Young has nothing to disclose.
Lucas Scárdua Silva, MD Dr. Silva has nothing to disclose.
Hanan Alsakka, MD Miss Alsakka has nothing to disclose.
George Park, DO Dr. Park has nothing to disclose.
Mary Safaeipour Miss Safaeipour has nothing to disclose.
Glenn D. Graham, MD, PhD, FAAN Dr. Graham has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker with MER (non-profit CME provider). Dr. Graham has received personal compensation in the range of $500,000-$999,999 for serving as a Employee with Department of Veterans Affairs. An immediate family member of Dr. Graham has received personal compensation in the range of $100,000-$499,999 for serving as a Exployee with Department of Veterans Affairs.
Jared Craig Wolfe Mr. Wolfe has nothing to disclose.
Linda S. Williams, MD, FAAN The institution of Dr. Williams has received research support from VA HSR&D.
Narmada Mannem, MBBS Dr. Mannem has nothing to disclose.
Ema Rodrigues, Other Dr. Rodrigues has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Rodrigues has stock in Alexion Pharmaceuticals.
Christopher Stave, Other Mr. Stave has nothing to disclose.
Timothy L. Vollmer, MD, FAAN The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Kumaraswamy Sivakumar, MD, MRCP Dr. Sivakumar has nothing to disclose.
Catharina Groß The institution of Catharina Groß has received research support from Biogen. The institution of Catharina Groß has received research support from Roche.
Martin Kerschensteiner, MD Prof. Kerschensteiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Kerschensteiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Aventis. Prof. Kerschensteiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Healtcare. Prof. Kerschensteiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Prof. Kerschensteiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Healthcare. Prof. Kerschensteiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Aventis. Prof. Kerschensteiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Li Liu, PhD Dr. Liu has received personal compensation for serving as an employee of Argenx .
Abby Bossart, MD Dr. Bossart has nothing to disclose.
Alexander Rodero Romero, PhD Mr. Rodero Romero has nothing to disclose.
Andreas Schulte-Mecklenbeck Andreas Schulte-Mecklenbeck has nothing to disclose.
Mordechai Z. Smith, MD Dr. Smith has nothing to disclose.
James Baumgartner, MD Dr. Baumgartner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PMT Corporation.
Maurizio F. Facheris, MD, MSc Dr. Facheris has received personal compensation for serving as an employee of AbbVie Inc.. Dr. Facheris has stock in AbbVie Inc..
Sanjay N. Rakhade, MBBS, PhD Dr. Rakhade has received personal compensation for serving as an employee of Alexion Pharmaceuticals . Dr. Rakhade has stock in Alexion Pharmaceuticals. Dr. Rakhade has stock in Astra Zeneca. Dr. Rakhade has received intellectual property interests from a discovery or technology relating to health care.
Sheffield Sharp, Other Mr. Sharp has stock in AbbVie. Mr. Sharp has stock in Abbott.
Yann Hyvert, PhD Dr. Hyvert has received personal compensation for serving as an employee of The healthcare business of Merck KGaA, Darmstadt, Germany. An immediate family member of Dr. Hyvert has received personal compensation for serving as an employee of The healthcare business of Merck KGaA, Darmstadt, Germany.
Peter Ulrichts Peter Ulrichts has received personal compensation for serving as an employee of argenx. Peter Ulrichts has stock in argenx.
Britney Barrera Ms. Barrera has nothing to disclose.
Meg Mendoza Meg Mendoza has nothing to disclose.
Sahara Cathcart Dr. Cathcart has nothing to disclose.
Rajesh K. Gupta, MBBS Dr. Gupta has nothing to disclose.
Niveta Aravind, MD Dr. Aravind has nothing to disclose.
Marie Sutherland Nunez, Other Ms. Nunez has nothing to disclose.
Jose Ronel N. Santos, MD An immediate family member of Dr. Santos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon Therapeutics. An immediate family member of Dr. Santos has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cochrane. Dr. Santos has stock in Gilead Sciences. Dr. Santos has stock in Novocure. Dr. Santos has stock in Shockwave Medical. Dr. Santos has stock in Teva. An immediate family member of Dr. Santos has received research support from American Academy of Neurology. The institution of an immediate family member of Dr. Santos has received research support from Trinity Health Saint Mary's Foundation. An immediate family member of Dr. Santos has a non-compensated relationship as a Delegate with AAN Neurology on the Hill that is relevant to AAN interests or activities. An immediate family member of Dr. Santos has a non-compensated relationship as a Participant with AAN Palatucci Advocacy Leadership Forum that is relevant to AAN interests or activities. An immediate family member of Dr. Santos has a non-compensated relationship as a Scholar with AAN Health Equity Symposium Scholarship that is relevant to AAN interests or activities. An immediate family member of Dr. Santos has a non-compensated relationship as a Participant with AAN Emerging Leaders Program that is relevant to AAN interests or activities.
Martine Neyens Mrs. Neyens has nothing to disclose.
Kathryn Zuchowski, MD Dr. Zuchowski has nothing to disclose.
Carmen Martinez Asensio, MD Mrs. Martinez Asensio has nothing to disclose.
Indu Meena, MBBS Dr. Meena has nothing to disclose.
Megan Amuan Megan Amuan has nothing to disclose.
Yaowei Zhu, PhD Dr. Zhu has received personal compensation for serving as an employee of Janssen Research & Development, LLC.
Jeffrey Alan Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage.
Angela L. Genge, MD Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE.
Paul Grunsted, Other Mr. Grunsted has nothing to disclose.
Renuka Verma, MD Dr. Verma has nothing to disclose.
Brian Werneburg Mr. Werneburg has received personal compensation for serving as an employee of Alexion.
Gary Kohanbash, PhD The institution of Dr. Kohanbash has received research support from NIH.
Nina Navalkar, MD Dr. Navalkar has nothing to disclose.
Yessar M. Hussain, MD The institution of Dr. Hussain has received research support from Alnylam Pharma.
Shoshana Reshef, PhD Dr. Reshef has received personal compensation for serving as an employee of Teva.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Malgorzata Zajda, MD,PhD Dr. Zajda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health.
Ran Tao, PhD Dr. Tao has nothing to disclose.
Cleo Zarina Alejo Reyes, MD Dr. Reyes has nothing to disclose.
Samantha Anne Gutierrez Samantha Anne Gutierrez has nothing to disclose.
Aaron Stephen Bower, MD Dr. Bower has nothing to disclose.
Michal T. Gostkowski, DO The institution of Dr. Gostkowski has received research support from Medtronic.
John Cirrito John Cirrito has nothing to disclose.
Tania Kuempfel, MD Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Pharma. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Vincent Vagni Vincent Vagni has nothing to disclose.
Anuradha Duleep, MD Dr. Duleep has nothing to disclose.
Leonel Takada No disclosure on file
Niko Nykanen, PhD Dr. Nykanen has nothing to disclose.
Mark Louis Vanderkelen, MD Dr. Vanderkelen has received personal compensation for serving as an employee of UCB Pharma. Dr. Vanderkelen has stock in UCB Pharma.
Carolina Barnett Tapia, MD Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $0-$499 for serving as a Consultant for Sanofi. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care.
Alexis Flowers, MD Dr. Flowers has received intellectual property interests from a discovery or technology relating to health care.
Lisa Eunyoung Lee Lisa Eunyoung Lee has nothing to disclose.
Patricia Prelock, PhD Dr. Prelock has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Publishing. The institution of Dr. Prelock has received research support from PCORI. The institution of Dr. Prelock has received research support from HRSA. Dr. Prelock has received publishing royalties from a publication relating to health care. Dr. Prelock has received publishing royalties from a publication relating to health care. Dr. Prelock has received publishing royalties from a publication relating to health care.
Osvaldo J M Nascimento, MD, PhD, FAAN Dr. Nascimento has nothing to disclose.
Pegah Masrori, MD Dr. Masrori has received research support from European Academy of Neurology.
Gerd Meyer Zu Horste, MD Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB. The institution of Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Meyer Zu Horste has received research support from Merck KGaA. The institution of Dr. Meyer Zu Horste has received research support from Roche. Dr. Meyer Zu Horste has received intellectual property interests from a discovery or technology relating to health care.
Sondra Zabar Sondra Zabar has nothing to disclose.
Gitanjali Das, MD Dr. Das has nothing to disclose.
Alain Lamontagne, PhD Dr. Lamontagne has received personal compensation for serving as an employee of Asklepios Biopharmaceutical Inc.
Umair Azhar Mr. Azhar has nothing to disclose.
Maryellen Campbell, MD Dr. Campbell has nothing to disclose.
Iqra *Use 379943 Faiz, Masters student Ms. Faiz has nothing to disclose.
Jianhua Han Mrs. Han has nothing to disclose.
Do-Yeon Lee, PhD Ms. LEE has nothing to disclose.
Timothy Lesnick Timothy Lesnick has received personal compensation for serving as an employee of Mayo Clinic.
Marie-Helene Jouvin Marie-Helene Jouvin has received personal compensation for serving as an employee of Fulcrum Therapeutics. Marie-Helene Jouvin has received personal compensation for serving as an employee of Pharvaris. Marie-Helene Jouvin has stock in Fulcrum Therapeutics. Marie-Helene Jouvin has stock in Pharvaris.
Francois Lauzier Francois Lauzier has nothing to disclose.
Miriam L. Freimer, MD, FAAN Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ra. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for immunovant. The institution of Dr. Freimer has received research support from Alnylum. The institution of Dr. Freimer has received research support from UCB. The institution of Dr. Freimer has received research support from NIH. The institution of Dr. Freimer has received research support from Janssen. Dr. Freimer has received research support from Avidity. Dr. Freimer has received research support from Fulcrum.
Grace Kathryn Bastin Miss Bastin has nothing to disclose.
Ashley Young Miss Young has nothing to disclose.
Arthur Simen Arthur Simen has received personal compensation for serving as an employee of Takeda.
Soroush Kakawand, MD Dr. Kakawand has nothing to disclose.
Nakul Katyal Dr. Katyal has nothing to disclose.
Sania Azhar Ms. Azhar has nothing to disclose.
Marc Rosenbaum, MD Dr. Rosenbaum has nothing to disclose.
Marina Solti Miss Solti has nothing to disclose.
Tobias Moser Mr. Moser has nothing to disclose.
Andrew J. Gordon, MD Dr. Gordon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion . Dr. Gordon has received personal compensation in the range of $0-$499 for serving as a Consultant for Vertex. Dr. Gordon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Gordon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Gordon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cassiday.
Nathaniel Pendleton Rogers, Jr., MD Mr. Rogers has nothing to disclose.
Tina Marie Maschi, PhD Dr. Maschi has nothing to disclose.
Robert Flinn, MD Dr. Flinn has nothing to disclose.
Matthias Goebeler, MD Prof. Goebeler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. The institution of Prof. Goebeler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Prof. Goebeler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. Prof. Goebeler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GSK. Prof. Goebeler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Prof. Goebeler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. The institution of Prof. Goebeler has received research support from Argenx. Prof. Goebeler has received personal compensation in the range of $0-$499 for serving as a travel expenses with UCB.
Alberto Velez Van Meerbeke, MD Dr. Velez Van Meerbeke has nothing to disclose.
Karissa Gable, MD Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape, Web MD. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmacy Times. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cowen. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenx. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Lecture series with Medscape.
Julian Gal, MD, MA Dr. Gal has nothing to disclose.
Marco M. Wolmarans Mr. Wolmarans has nothing to disclose.
Stephan Ortiz, PhD Dr. Ortiz has received personal compensation for serving as an employee of Alexion/AstraZeneca Rare Disease. Dr. Ortiz has stock in Alexion.
Kasun Indika Navarathna, MD Dr. Navarathna has nothing to disclose.
Ariana Meldaña Rivera Ariana Meldaña Rivera has nothing to disclose.
Sakinah Sabadia, MD Dr. Sabadia has nothing to disclose.
Bichum Ouyang The institution of Bichum Ouyang has received research support from NIH.
Yuan Xiong, PhD Dr. Xiong has received personal compensation for serving as an employee of Janssen Pharmaceuticals. Dr. Xiong has stock in Janssen Pharmaceuticals.
Jeremias Motte, MD The institution of Dr. Motte has received research support from Ruhr-Univerity Bochum.
Manik Tetarbe, MD Dr. Tetarbe has nothing to disclose.
J Daniel Obray, PhD Dr. Obray has nothing to disclose.
Trilok Stead Trilok Stead has nothing to disclose.
Edward Brauer Edward Brauer has received personal compensation for serving as an employee of argenx. Edward Brauer has stock in argenx.
Sailaja Sanikommu, MBBS Dr. Sanikommu has nothing to disclose.
Pooja Gupta, MD Dr. Gupta has nothing to disclose.
Keith Tan, MD,PhD Dr. Tan has received personal compensation for serving as an employee of AstaZeneca. An immediate family member of Dr. Tan has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for SOBI. Dr. Tan has stock in AstraZeneca.
Wuttipong Tirakotai No disclosure on file
Rahul Mahapatra, DO Dr. Mahapatra has nothing to disclose.
Saranya B. Gomathy, MD Dr. Gomathy has nothing to disclose.
Gianvito Masi, MD Dr. Masi has nothing to disclose.
Jan L. De Bleecker, MD, PhD, FAAN Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgNX. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring.
Syed Omar Shah, MD Dr. Shah has nothing to disclose.
Nigar Dargah-Zada, MD Dr. Dargah-Zada has nothing to disclose.
Rajinder Kumar Dhamija, MD, FRACP Prof. Dhamija has nothing to disclose.
Alexandra Raquel Santana Almansa, MD Dr. Santana Almansa has nothing to disclose.
Michael A Perez, MD Dr. Perez has nothing to disclose.
Oscar Harari, PhD Dr. Harari has nothing to disclose.
Azizi Seixas Azizi Seixas has nothing to disclose.
Jieun Kang, MD Dr. Kang has nothing to disclose.
Shahram Izadyar, MD The institution of Dr. Izadyar has received research support from Xenon Pharmaceuticals. The institution of Dr. Izadyar has received research support from Ostuka Pharmaceuticals. An immediate family member of Dr. Izadyar has received publishing royalties from a publication relating to health care.
Nirav Pavasia, MD Dr. Pavasia has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pavasia has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Pavasia has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Pavasia has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. Dr. Pavasia has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Mariam Al Hussona, MB BCh BAO Dr. Al Hussona has nothing to disclose.
Mohamed Afify, MD Dr. Afify has nothing to disclose.
Barbara Gisevius, PhD Dr. Gisevius has nothing to disclose.
Petras Jairam Das Lohana, MD,MBBS Dr. Jairam Das Lohana has nothing to disclose.
Michael K. Hehir, II, MD Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Hehir has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hehir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Hehir has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum- American Academy of Neurology. Dr. Hehir has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. The institution of Dr. Hehir has received research support from Myasthenia Gravis Foundation of America. The institution of Dr. Hehir has received research support from University of Vermont Medical Center.
Chelsea Schmoll, DO Dr. Schmoll has nothing to disclose.
Christina Small, Other Ms. Small has nothing to disclose.
Sofiane Agha, MD Dr. Agha has received personal compensation for serving as an employee of argenx.
Ali Gheidi Dr. Gheidi has nothing to disclose.
Abhilash Thatikala, MD, MBBS, DM Dr. Thatikala has nothing to disclose.
Ryan Hays, MD, MBA, FAAN, FAES Dr. Hays has nothing to disclose.
Robert S. Raike, PhD Dr. Raike has received personal compensation for serving as an employee of Medtronic. Dr. Raike has received intellectual property interests from a discovery or technology relating to health care.
Karen Halldorsdottir, MD Dr. Halldorsdottir has nothing to disclose.
Matthew Vibbert, MD Dr. Vibbert has nothing to disclose.
Annet Storm, Other Miss Storm has nothing to disclose.
Lucienne Costa Costa-Frossard Franca, Sr., PhD Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biopas. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristoll-Mayer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Scott Stanslaski Scott Stanslaski has received personal compensation for serving as an employee of Medtronic. Scott Stanslaski has received stock or an ownership interest from Medtronic. Scott Stanslaski has received intellectual property interests from a discovery or technology relating to health care.
Diego Silva Diego Silva has received personal compensation for serving as an employee of BMS. Diego Silva has received stock or an ownership interest from BMS.
Irena Dujmovic Basuroski, MD, PhD The institution of Dr. Dujmovic Basuroski has received research support from Alexion Pharmaceuticals, Inc. The institution of Dr. Dujmovic Basuroski has received research support from Biogen MA Inc. The institution of Dr. Dujmovic Basuroski has received research support from EMD Serono Research and Development Institute, Inc . The institution of Dr. Dujmovic Basuroski has received research support from Celgene Corporation/Bristol-Myers Squibb. The institution of Dr. Dujmovic Basuroski has received research support from The Bodford Family Transverse Myelitis Center Fund.
Judith Bellmann-Strobl, MD Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Judith Bellmann-Strobl, MD has received research support from Bayer. The institution of Judith Bellmann-Strobl, MD has received research support from NEMOS.
Marzena Pedrini, PhD Dr. Pedrini has nothing to disclose.
Scott Weber, PhD Dr. Weber has nothing to disclose.
Qiang Chen, PhD The institution of Dr. Chen has received research support from National Science Foundation.
Bradley Folley No disclosure on file
Eric Stulberg, MD Dr. Stulberg has nothing to disclose.
Sofia Vakhtang Kasradze, MD Prof. Kasradze has nothing to disclose.
Niall Warfield, MBBS Dr. Warfield has nothing to disclose.
Julian Thomas, MD Dr. Thomas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Robert A. Hauser, MD, MBA, FAAN Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Global Kinetics Consulting (GKC). Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDerm. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion Neurostim LLC. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tolmar Inc.. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus Pharma. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inhibikase. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pharma 2 B. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivifi Biotech. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ovid Therapeutics. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AgeX Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanex. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MDCE Suzhou. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PDNeurotechnology. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regenxbio. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Tremor Research Support Group. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tris Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda Therapeutics. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Ameal . Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sunovion. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Cerevel. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Inhibikase. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has stock in Inhibikase. Dr. Hauser has stock in Axial Therapeutics. Dr. Hauser has stock in Enterin. Dr. Hauser has stock in Revance Therapeutics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Artizan Biosciences. The institution of Dr. Hauser has received research support from Parkinsons & Movement Disorder Alliance. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Aeon Biopharma. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Bukwang Pharmaceutical Co., Ltd.. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Cynapsus Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Impax Labratories. The institution of Dr. Hauser has received research support from Integrative Research Labratories Sweden. The institution of Dr. Hauser has received research support from Lundbeck, Inc.. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuraly Inc.. The institution of Dr. Hauser has received research support from Neurocrine Biosciences. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Pharma Two B Ltd.. The institution of Dr. Hauser has received research support from Revance Therapeutics. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Sanofi Pharmaceuticals. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from SunPharma. The institution of Dr. Hauser has received research support from UCB BioPharma. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Prashanthi Vemuri, PhD Dr. Vemuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Miller Medical Communications Inc.. The institution of Dr. Vemuri has received research support from NIH.
Jung-Joon Sung, MD,PhD Prof. Sung has nothing to disclose.
Ali A. Habib, MD Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Immune Sciences. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from VielaBio. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Genentech. The institution of Dr. Habib has received research support from Regeneron.
Leona Ling, PhD Dr. Ling has received personal compensation for serving as an employee of Janssen Pharmaceuticals (Johnson&Johnson). Dr. Ling has stock in Janssen Pharmaceuticals (Johnson&Johnson). Dr. Ling has received intellectual property interests from a discovery or technology relating to health care. Dr. Ling has received intellectual property interests from a discovery or technology relating to health care.
Timothy R. Lim Timothy R. Lim has nothing to disclose.
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Susana Sainz de la Maza Susana Sainz de la Maza has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall, Biogen, Merck, Novartis, Roche and Sanofi-Genzyme.
Caleb Pearson, PhD Dr. Pearson has received publishing royalties from a publication relating to health care.
Humay Ismayilzada, III, MD Mr. Ismayilzada has nothing to disclose.
Luisa M. Villar Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers Squibb. The institution of Luisa M. Villar has received research support from European Union. The institution of Luisa M. Villar has received research support from Instituto de Salud Carlos III (Spanish Goverment).
Michael Pomfret No disclosure on file
Adel Hijazi Mr. Hijazi has nothing to disclose.
Matthew Gusler, DO Dr. Gusler has nothing to disclose.
Alexander G. Doyle, MD Dr. Doyle has nothing to disclose.
Jordan Yorgason, PhD The institution of Dr. Yorgason has received research support from American Osteopathic Association.
Soonhyun Yook, PhD Dr. Yook has nothing to disclose.
Karan Patel Mr. Patel has nothing to disclose.
Rohan Sharma, MD Dr. Sharma has nothing to disclose.
Nicholas Yelverton, DO Dr. Yelverton has nothing to disclose.
Houari Korideck, MD Dr. Korideck has nothing to disclose.
Jasmine Parihar, DM Dr. Parihar has nothing to disclose.
Christopher David Lee, MD Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Solomon Oak Mr. Oak has nothing to disclose.
Catherine Broome, MD Dr. Broome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Broome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Broome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Broome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Incyte. The institution of Dr. Broome has received research support from Argenx. The institution of Dr. Broome has received research support from Sanofi. The institution of Dr. Broome has received research support from Incyte. The institution of Dr. Broome has received research support from Rigel.
Davorka Tomic No disclosure on file
Peter Victoria, Other Mr. Victoria has nothing to disclose.
Nathalie Cartier, MD Dr. Cartier has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for askbio. Dr. Cartier has stock in brainvectis.
Nicholas Karagas, MD An immediate family member of Dr. Karagas has received personal compensation for serving as an employee of Thirty Madison. An immediate family member of Dr. Karagas has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Thirty Madison. An immediate family member of Dr. Karagas has stock in Thirty Madison.
Marc A. Swerdloff, MD Dr. Swerdloff has nothing to disclose.
Nomesh Kumar, MD Dr. Kumar has nothing to disclose.
Nathaniel Gray Wooten, MD Dr. Wooten has nothing to disclose.
Achal K. Srivastava, MD, FAAN Dr. Srivastava has nothing to disclose.
Ke Li, MD Dr. Li has nothing to disclose.
Jessika Suescun, MD Dr. Suescun has nothing to disclose.
Joel E. Kleinman, MD,PhD Dr. Kleinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Kleinman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Austin Sidley law Firm.
Baukje Bijnens An immediate family member of Miss Bijnens has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck . The institution of Miss Bijnens has received research support from University of Antwerp .
Awadh K. Pandit Awadh K. Pandit has nothing to disclose.
Ronak Uday Trivedi Mr. Trivedi has nothing to disclose.
Victor Manuel Torres-Lopez, MA Mr. Torres-Lopez has nothing to disclose.
Kyle T. Mitchell, MD Dr. Mitchell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Mitchell has received research support from Medtronic. The institution of Dr. Mitchell has received research support from Deep Brain Innovations. The institution of Dr. Mitchell has received research support from National Institutes of Health. The institution of Dr. Mitchell has received research support from National Institute on Aging.
Rita Elias, DO Dr. Elias has nothing to disclose.
Gary Raymond Cutter, PhD Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Sciences International, Biogen, Click Therapeutics, Genzyme, Genentech, GW Pharmaceuticals, Immunic, Klein-Buendel Incorporated, Medimmune/Viela Bio, Medday, Merck/Serono, Neurogenesis LTD, Novartis, Osmotica Pharmaceuticals, Perception Neurosciences, Recursion/Cerexis Pharmaceuticals, Regeneron, Reckover Pharmaceuticals, Roche, TG Therapeutics.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics, AI therapeutics, AMO Pharma, Astra-Zeneca, Avexis Pharmaceuticals, Biolinerx, Brainstorm Cell Therapeutics, Bristol Meyers Squibb/Celgene, CSL Behring, Galmed Pharmaceuticals, Green Valley Pharma, Horizon Pharmaceuticals, Immunic, Karuna Therapeutics, Mapi Pharmaceuticals LTD, Merck, Mitsubishi Tanabe Pharma Holdings, Opko Biologics,Prothena Biosciences, Novartis, Regeneron, Sanofi-Aventis, Reata Pharmaceuticals, NHLBI (Protocol Review Committee), University of Texas Southwestern, University of Pennsylvania, Visioneering Technologies, Inc.. Dr. Cutter has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Kamil Taneja Mr. Taneja has nothing to disclose.
Reshma Bano Shahzadi, MBBS Dr. Shahzadi has nothing to disclose.
Sara Wesley Hyman Ms. Hyman has nothing to disclose.
Jing Yang No disclosure on file
Philip Van Damme The institution of Dr. Van Damme has received research support from CSL Behring.
Ayush Agarwal, DM Dr. Agarwal has nothing to disclose.
Darren David Christy Mr. Christy has nothing to disclose.
Kuntal *Use 379068 Biswas, MD Dr. Biswas has nothing to disclose.
Belen Valenzuela, PhD Dr. Valenzuela has nothing to disclose.
Rahul A. Bharadwaj, PhD Dr. A Bharadwaj has nothing to disclose.
Maria Isabel Leite, MD The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela/Horizon. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Leite has received research support from Non-Profit Organization - Myaware. The institution of Dr. Leite has received research support from UCB - Ra Pharma.
Alyssa Carlson Ms. Carlson has nothing to disclose.
Franziska Wichern Mrs. Wichern has received personal compensation for serving as an employee of Gubra ApS.
Lorne H. Zinman, MD Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, MTP, AB Science, Cytokinetics, Amylyx. Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Koroboshka Brand-Arzamendi, Other Mrs. Brand-Arzamendi has nothing to disclose.
Su Jung Choi, PhD,RN Ms. Choi has nothing to disclose.
Pascal Benkert Pascal Benkert has nothing to disclose.
Elda María Maria Alba Suarez, PhD Mrs. Alba Suarez has nothing to disclose.
Renata Cavalcanti Eiras, MD Miss Eiras has nothing to disclose.
Muhammad Sulman Bhatti, MD Dr. Bhatti has nothing to disclose.
Gabriela Alejo, MD Dr. Alejo has nothing to disclose.
Fatai Momodu Akemokwe, MBBS Dr. Akemokwe has stock in CVS HEALTH CORP. Dr. Akemokwe has stock in LABORATORY CORP AMERICAN HOLDINGS.
Alex Dombrowski No disclosure on file
Mark Boulos, MD Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Paladin Labs. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. The institution of Dr. Boulos has received research support from Canadian Institutes of Health Research. The institution of Dr. Boulos has received research support from Slamen-Fast New Initiatives in Neurology Award. The institution of Dr. Boulos has received research support from Green Mountain . The institution of Dr. Boulos has received research support from RLS Foundation. The institution of Dr. Boulos has received research support from Temerty Centre for AI Research and Education in Medicine (T-CAIREM). The institution of Dr. Boulos has received research support from Heart & Stroke Foundation of Canada. The institution of Dr. Boulos has received research support from Alternative Funding Plan from the Academic Health Sciences Centres of Ontario. Dr. Boulos has received personal compensation in the range of $5,000-$9,999 for serving as a speaker with Jazz Pharmaceuticals.
Patrick J. Lavin, MB, BCh Dr. Lavin has nothing to disclose.
Andrew Payne, PhD Dr. Payne has nothing to disclose.
Aaron M. Ring No disclosure on file
Kara Rice Mrs. Rice has received personal compensation for serving as an employee of AstraZeneca. Mrs. Rice has stock in AstraZeneca.
George Li, MD Dr. Li has nothing to disclose.
Allan G. Kermode, MD,FRACP,MBBS Dr. Kermode has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kermode has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche.
Timothy Michael Ellmore, PhD The institution of Prof. Ellmore has received research support from NIMH.
Viktoras Palys, MD,Other Dr. Palys has nothing to disclose.
Madeline Chiujdea Madeline Chiujdea has nothing to disclose.
Amrita Pandey, MD Dr. PANDEY has nothing to disclose.
Natasha Thomas Miss Thomas has nothing to disclose.
Dietmar Thal No disclosure on file
Sayyeda Zahra, MD Dr. Zahra has nothing to disclose.
Keri Feldman, Other Ms. Feldman has nothing to disclose.
Benjamin Williams Mr. Williams has nothing to disclose.
Thor Ostenfeld, MBBS,PhD Dr. Ostenfeld has received personal compensation for serving as an employee of AstraZeneca. Dr. Ostenfeld has stock in AstraZeneca. Dr. Ostenfeld has received intellectual property interests from a discovery or technology relating to health care.
Matthew Rosebraugh, PhD Dr. Rosebraugh has received personal compensation for serving as an employee of AbbVie Inc. Dr. Rosebraugh has stock in AbbVie Inc..
Nadia Sial, MD Ms. Sial has nothing to disclose.
Victor W. Sung, MD Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Neuroscience. Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Sung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure.
Lorena Adolphsson No disclosure on file
Nandakumar Narayanan, MD, PhD Dr. Narayanan has nothing to disclose.
Muhammed Ors Mr. Ors has nothing to disclose.
Ye Su, DO Dr. Su has nothing to disclose.
Michael O'Callaghan, PhD,Other Dr. O'Callaghan has received personal compensation for serving as an employee of Asklepios Biopharmaceuticals. Dr. O'Callaghan has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Asklepios Biopharmaceuticals. Dr. O'Callaghan has stock in Asklepios Biopharmaceuticals. Dr. O'Callaghan has received intellectual property interests from a discovery or technology relating to health care.
Simon Laganiere, MD Dr. Laganiere has received research support from HDSA.
Shaheen Sombans, MBBS Dr. Sombans has nothing to disclose.
Stefanie Jordan Rodenbeck, MD Dr. Rodenbeck has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals.
Cameron J. Davidson, PhD Dr. Davidson has nothing to disclose.
Katrina Anderson Katrina Anderson has received personal compensation for serving as an employee of American Academy of Neurology.
Sherry Fung Ms. Fung has nothing to disclose.
Rafael Joao Mr. Joao has nothing to disclose.
Shima Zargar, MD Dr. Zargar has nothing to disclose.
Nily Osman, MD No disclosure on file
Nayla Chaijale Nayla Chaijale has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Nilab Osman, MD Dr. Osman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biovie.
Sahar Nozad The institution of Sahar Nozad has received research support from Clarix Imaging Corporation.
Wilgee Eila Sun Abbot, MD Dr. Abbot has nothing to disclose.
Christian Wichmann Dr. Wichmann has received personal compensation for serving as an employee of Novo Nordisk.